Puration Celebrates SPEC’s Wines Spirits and Finer Foods Little Elm Texas Grand Opening With EVERx CBD Sports Water Free Samp…

Dallas, TX — Aug 17, 2018 — InvestorsHub Newswire — Puration, Inc. (USOTC: PURA) today announced it will be giving out free samples of its EVERx CBD Infused Sports Water at the Grand Opening of SPEC’s Wines Spirits & Finer Foods newest store in Little Elm, Texas (27100 HWY 380 Denton, TX 75068). 

 



Founded in 1962 by Carroll “Spec” and Carolynn Jackson, SPEC’s today operates 170 retail locations.  In addition to selling spirits, wine and beer, SPEC’s stores include deli and specialty groceries.  SPEC’s is a well know brand name in Texas and continuing to expand its reach to new locations.

Puration introduced EVERx CBD Infused Sports Water last year, in 2017 at Arnold Schwarzenegger’s Arnold Sports Festival. EVERx has since become the leading CBD infused beverage in the sports and fitness marketplace. EVERx CBD Infused Sports Water has a clean and refreshing taste that comes with 10mg of CBD per 500ml bottle and an optimal alkaline pH level formulated with antioxidants and electrolytes The EVERx formula is backed by two patents. In addition to the clean and refreshing taste of EVERx natural water, EVERx is available in lemon-lime and strawberry-kiwi flavors.

Corona Beer Parent Constellation Brands Invests $200 Million In Cannabis Beverages

Market research firm Technavio predicts that the cannabis-infused food and beverage products market will register a CAGR of more than 25% from 2018 to 2022. Research firm Cowen & Co. reports U.S. legal cannabis industry sales growth is on track to surpass soda sales by 2030.  Global alcohol giant Constellation Brands (Corona Beer, among others) purchased a 9.9% stake in Canada’s largest licensed producer, Canopy Growth, for 245 million Canadian dollars (US$190 million), plus options to raise its stake to just under 20%. Puration management is preparing the company for the cannabis infused food and beverage market boom.

Puration has recently announced a corporate reorganization plan to consolidated and concentrate its cannabis beverage operations.  The reorganization plan includes the issuance of a dividend to Puration shareholders.  Learn more about the reorganization plan in recent press release dedicated to detailing the reorganization plan.

For more information on SPEC’s, visit https://specsonline.com/
For more information on EVERx, visit https://www.aciconglomerated.com/pura
For more information on Puration, visit http://www.aciconglomerated.com.

Disclaimer/Safe Harbor: 

This news release contains forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. 

Puration, Inc.

Brian Shibley,
info@aciconglomerated.com

(800) 861-1350


 

https://ih.advfn.com/p.php?pid=nmona&article=78095871

Bityond ICO: Decentralizing Recruitment [EN]

*this article was written by Bityond’s founder, with the purpose of promoting the project and ICO. Thank you in advance for your time and attention!

Hello there.

I’m Pedro, the founder of Bityond.

I want to share with you my ideas on how we could possibly solve some issues in recruitment and talent management, by connecting people by skills and experience while creating an economic incentive for all users in the Bityond network.

The goal of decentralization is to give back power to users.

And we all know power = money.

So the only way to actually give power back is by rewarding users for participating in the Bityond network.

With an actual utility token!

We aim to integrate BYT tokens in our application, which will be given for free to users upon completing certain actions. Tokens will entitle users to voting and purchase new developments or buy employer subscriptions and reporting.

Bityond matches candidates to jobs, by skills and experience. Our matching tool uses standardized skills for an accurate matching between candidates and employers.

Companies can use Bityond to both recruit and manage talent internally!

All in one place.


Bityond is the official sponsor of IST sports teams
 

Version 1 is already out and available. Sign in and give it a try!

Version 2, coming out in Q3 2018, is improving the design and adding some cool features as reviews and an interviews module for recruiters. Please share you comments and thoughts. Any feedback is valuable, as it’s the only way to improve this idea!


sneak-peak of version 2.0, coming out in Q4 2018

Version 3, to be released Q1 2019, will incorporate smart-contracts to enable economic incentives.

This means you can start earning tokens by using Bityond.

Just a gentle reminder: it’s all 100% free.

Call that a deal!
 

How will funds be spent?

As cool as Bityond already sounds, we do need to raise funds in order to grow the project. We’ll be spending funds mainly on marketing and developing Bityond 3.0

Bityond tokens will also serve the useful purpose of paying Bityond contributors and team members.

Who is Bityond?

Check Bityond’s ICO page to see with more detail.


https://www.bityond.com/ico

ICO Details

Name: Bityond ICO,

Token: Bityond Token,

Symbol: BYT,

ICO Date: 15 May 2018–15 September 2018 (ongoing),

Total Supply: 100,000,000.00 BYT,

Investors: 40,000,000.00 BYT,

Team: 10,000,000.00 BYT,

Bityond Users: 50,000,000.00 BYT,

Price 1 BYT: 0.00001 ETH,

Total Funds Raised: 400 ETH.

Crowdsale address on etherscan.
Bityond Token onetherscan.

Useful Links

Bityond platform,

Bityond ICO,

Bityond Whitepaper,

Bityond on ICOBench

Bityond Telegram,

Bityond Discord,

Bityond Facebook,

Bityond Twitter,

Bityond Linkedin,

Bityond onYoutube

Thank you!!!

Share your opinion, thoughts, comments and feedback. It’s the only way we can make this whole thing better!

Don’t forget to check our ICO Page!


Guess who we met at TechCruch Sessions Blockchain 2018?!

Thank you for your support!

Let’s build the best recruitment network on the web!

Talk to me directly @Pedro Febrero Jr. or in twitter @Febrocas

https://ih.advfn.com/p.php?pid=nmona&article=78087322

DISTRICT COPPER ACQUIRES 130 SQ. KM PROJECT CONTIGUOUS TO AND ON STRIKE WITH SOKOMAN’S MOOSEHEAD GOLD PROJECT


142 – 1146 Pacific Blvd.,
Vancouver, British Columbia V6Z 2X7 Canada
Telephone: (604) 620-7737
www.districtcoppercorp.com


DISTRICT COPPER ACQUIRES 130 SQ. KM PROJECT CONTIGUOUS TO AND ON STRIKE WITH SOKOMAN’S MOOSEHEAD GOLD PROJECT

Vancouver, BC — August 15, 2018 — InvestorsHub NewsWire — District Copper Corp. (“District Copper” or the “Company”) (TSX-Venture: DCOP) is pleased to announce that it has signed an agreement with an arm’s length third party to acquire, subject to TSX Venture Exchange approval, a 13,025 ha land package known as the Stony Lake East Gold Project contiguous to, and on strike with, Sokoman Iron Corporation’s (“Sokoman”) high-grade, low-sulfidation, epithermal-style Moosehead Gold Project (“Moosehead”) located in the Province of Newfoundland.

Highlights:


  • A purchase of a 100% interest in and to a 130 sq. km land package consisting of 521 claims (subject to a 2% – 3% net smelter return royalty);
  • The Project boundary is located 2.5 km southwest of Sokoman’s high-grade gold discovery drill hole;
  • There are 18 known gold occurrences that exhibit epithermal style alteration and mineralization in bedrock / subcrop with rock grab sample results of up to 15.1 g/t gold; and
  • Soil, till and lake sediment sampling has identified multiple, coincident, large gold geochemical anomalies.

Sokoman recently reported that its first drill hole, MH-18-01, at Moosehead (see Sokoman’s News Release dated July 24, 2017) returned 11.9 m of 44.96 g/t gold from 109.0 m to 120.9 m.

Stony Lake East Gold Project is located near Grand Falls-Bishops Falls in central Newfoundland.

District Copper President & CEO, Jevin Werbes comments, “This is a large and highly prospective gold project in a rich geological setting. The land package, notably put together prior to the Sokoman’s discovery, was carefully assembled by a well-known and respected Newfoundland geologist and project generator based on data of geological merits identified by past explorers (such as Norada), giving the project significant upside. The fact that Sokoman now has a significant high-grade gold discovery next door to Stony Lake should only accelerate capital markets interest in what is already a very exciting project.”

Project Description/Exploration Results:

The Stony Lake project covers approximately 27 km of strike length of upper Silurian age sandstones-siltstones. Six large exploration targets have been identified. These areas exhibit a combination of some or all of the following; 

 


  • lower-grade (<4 g Au/t) auriferous alteration zones (argillic and silicification)
  • linear quartz-rich zones with gold concentration ranging from highly anomalous to gold values up to 15.1 g Au/t.
  • mineralization hosted in quartz veins, stockworks and quartz breccia exhibiting crustiform, cockscomb, chalcedonic banding
  • low levels (total sulfide is generally <2-3%) of fine-grained disseminated pyrite, arsenopyrite and sulfosalts; ginguro-style banding occurs at several localities with highly anomalous Au, Ag & Sb values
  • Soil, till and lake sediment sampling has identified multiple, coincident large gold geochemical anomalies
  • Elongated silica-rich structures that exhibit an apparent direct spatial relation to linear magnetic signatures.

The recent announcement by Sokoman, has drawn considerable attention to the gold potential of this area of Newfoundland.  It is important to note that the area covered by Stony Lake has yet to have undergone a thorough geological evaluation as a gold environment despite the numerous gold showings and highly anomalous gold geochemical results within and adjacent to the Project area. 

Historical exploration includes: preliminary regional geochemical sampling, limited prospecting, no diamond drilling except for a small area on the Flyers grid area of the property and partial airborne geophysical coverage. The coincident geochemical anomalies and anomalous to high gold concentrations in rock samples from the six separate zones identified to date attest to the quality of this underexplored and highly prospective Project. The results to date indicate a very high potential for a significant new gold discovery in an area with well-developed infrastructure in a mining friendly region.

Regional Setting:

The Stony Lake Property is located within an important regional structural zone striking through Southwest, Central and Northeast Newfoundland.  This structural zone controls the distribution of gold mineralization in this part of Newfoundland and hosts Benton Res.-Matador Res. Cape Ray gold deposits, Quadro Resources Staghorn gold zones, Marathon’s Valentine Lake gold camp, Antler Gold’s recently discovered high-grade gold zones, the Twilight gold zone, the new SIC Moosehead discovery and very likely Stony Lake’s gold showings.

Acquisition Terms:
The Stony Lake Property is being acquired by District Copper from 1174587 BC Ltd.; (the “Vendor”) a private British Columbia Corporation, in consideration of 40,000,000 common shares of District Copper (to be distributed among the Vendor’s six shareholders on a pro-rata basis). The Project is subject to an existing 2% Net Smelter Royalty, if the price of gold is US$2000/oz. or less, and 3.0% if the price of gold is above US$2000/oz.  As part of the agreement, District Copper has agreed to undertake exploration expenditures of:

 (i)  $150,000 on or before December 31, 2018,
(ii) an aggregate of $1,250,000 on or before December 31, 2019,
(iii) an aggregate of $2,500,000 on or before December 31, 2020, and
(iv) an aggregate of $4,000,000 on or before December 31, 2021

Elmer B. Stewart, P.Geol., a Director of District Copper, is a Qualified Person as defined in National Instrument 43-101 and has reviewed and approved the technical information contained in this news release.

About District Copper

District Copper is a publicly traded Canadian exploration company listed on the TSX-Venture Exchange (TSX.V: DCOP) focused on the exploration and development of porphyry copper-gold-molybdenum deposits in northwestern British Columbia. Additionally, the acquisition of the Stony Lake Gold Project in Newfoundland compliments District Copper’s Matachewan gold project located 3 km east of the Young Davidson gold mine in Ontario, establishing the Company as a major land holder in one of North America’s most exciting new gold camps.

For further information, please visit the website at www.districtcoppercorp.com to view the Company’s profile or contact Jevin Werbes at 604-620-7737.

                                                           
Jevin Werbes, President & CEO

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release does not constitute an offer to sell or a solicitation of an offer to sell any of the securities described herein in the United States. The securities described in this news release have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. This news release is not for distribution in the United States or over United States newswires.

Cautionary Statement on Forward Looking Statement

Information contained in this news release, including information as to strategy, projects, plans or future financial or operating performance and other statements that express management’s expectations or estimates of future performance, constitute “forward looking statements”. Actual results may differ materially from those indicated by such statements. All statements, other than historical fact, included herein, including, without limitations statements regarding future production, are forward-looking statements that involve various risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Forward-looking information in this news release includes, but is not limited to, statements about the exploration program at the Stony Lake project, the identification of six exploration targets, epithermal style alteration and mineralization, anomalous areas defined by geochemical sampling, structural setting of other zones of gold mineralization, the reference to the style and grade of the gold mineralization in the Moosehead zone and statements about District Copper’s strategy, future operations and prospects. There is no assurance that the transaction to acquire the Stony Lake project will complete on a timely basis or at all; that additional exploration may not located the style and concentration of gold mineralization located to date on the property, additional exploration may not located gold mineralization similar to that in the Moosehead zone or any gold mineralization at all, there is no  assurance that District Copper will be able to fund the exploration expenditures required to fund the acquisition of 100% of the Property or adequately fund future exploration programs.
 
A more complete discussion of the risks and uncertainties facing District Copper is disclosed in District Copper’s continuous disclosure filings with Canadian securities regulatory authorities at www.sedar.com. All forward-looking information herein is qualified in its entirety by this cautionary statement, and District Copper disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.

 

https://ih.advfn.com/p.php?pid=nmona&article=78078520

GetFugu, Inc. Private California Fund Commits To a $600k Investment to Enter the Military Drone and Aerospace Technology Indu…


GetFugu, Inc.

GetFugu, Inc. Private California Fund Commits To a $600k Investment to Enter the Military Drone and Aerospace Technology Industry

 

West Hollywood, CA — August 15, 2018 — InvestorsHub NewsWire — (OTC: GFGU) is developing the next generation of military drones. The unique technology will help fight against china and Russia.

The Company’s main goals for 2018 is to finalize a $1.2M fundraising campaign and to obtain a government contract which is currently in negotiations. This will allow us to become a significant player in the Military Drone and Aerospace Technology Industry.

Military Drone Market is expected to grow at a CAGR of around 8% during 2016-2021

The key factors driving the growth are increased demand of UAVs in military application, integration of drone in the current warfare systems to combat or counter threats and cost efficient as compared to manned aircraft. https://www.directionsmag.com/pressrelease/4977

The Company will keep its shareholders and the public completely informed of the entire process as details continue to develop.  Please watch for regular press releases on the Company’s progress. For more information, please follow us via our new twitter https://twitter.com/OTCGFGU

About 

GFGU is developing the next generation of military drones. The unique technology will help fight against China and Russia.

CONTACT:

 

Richard Jenkins

Phone:  7602187295

Twitter: https://twitter.com/OTCGFGU

Email: info@getfugu.com

https://ih.advfn.com/p.php?pid=nmona&article=78078083

International Stem Cell Corp Announces Record Sales and Operating Results for the Three and Six-Months ended June 30, 2018


International Stem Cell Corporation Announces Record Sales and Operating Results for the Three and Six-Months ended June 30, 2018


CARLSBAD, CA — Aug 15, 2018 — InvestorsHub NewsWire — International Stem Cell Corporation (OTCQB:ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based clinical stage biotechnology company developing novel stem cell-based therapies and biomedical products, today provided a business update and announced operating results for the three and six months ended June 30, 2018.


I’m pleased with our progress as ISCO continues to move forward actively in several areas. Recently we achieved another important milestone: transplanting the highest number of neural stem cells to the first Parkinson’s disease patient in the third cohort of patients in our phase 1 clinical trial. We plan to announce the 6 month results from the second cohort of patients before the end of Q3. Our financial results also show stable growth, and we were able to achieve record sales and to significantly decrease our loss from operations” said Andrey Semechkin, PhD., CEO and Co-Chairman of ISCO.


Year-to-Date Financial Highlights


  • Consolidated revenue for the six months ended June 30, 2018 was $5.7 million, an increase of 50% compared to the consolidated revenue of $3.8 million for the six months ended June 30, 2017.
  • Gross profit margin for the Company’s revenue-generating subsidiaries for the six months ended June 30, 2018 was $3.8 million, compared to gross profit margin of $2.7 million for the six months ended June 30, 2017.
  • Combined operating income for the six months ended June 30, 2018 from our two wholly owned revenue generating subsidiaries was $1.5 million, an increase of 53% compared to $974,000 in the same period in 2017.
  • Consolidated loss before income taxes, including from Parkinson’s disease clinical trial expenses, for the six months ended June 30, 2018 was $1.2 million, compared to consolidated loss before income taxes of $2.5 million for the same period in 2017
  • Average net cash used in operating activities, excluding capital expenditures and patent costs, was approximately $93,000 per month during the six months ended June 30, 2018, a decrease of 58%, compared to $222,000 per month for the same period in 2017.

Recent Corporate and Clinical Trial Highlights


  • Successfully transplanted the first patient in the third cohort of patients in the clinical trial for Parkinson’s disease. The patient received 70,000,000 ISC-hpNSC cells.
  • Published two papers in scientific peer-reviewed journals. One paper, entitled “Novel Approach to Stem Cell Therapy in Parkinson’s Disease,” was published in Stem Cells and Development, a premier peer-reviewed journal of clinical, basic, and translational research on stem cells and their potential therapeutic applications. Another paper, entitled “Supplementation of Specific Carbohydrates Results in Enhanced Deposition of Chondrogenic-Specific Matrix during Mesenchymal Stem Cell Differentiation,” was published in the Journal of Tissue Engineering and Regenerative Medicine, a prestigious peer-reviewed scientific journal. Due to its scientific relevance, the article was featured on the cover of the journal’s May 2018 issue.
  • Developed a novel method that efficiently generate human 3D liver-like tissue. The 3D liver structures are produced from human pluripotent stem cell derived-liver progenitor cells. As these cells differentiate in 3D culture, they form liver-like tissue that consists of hepatocytes, choangiocytes, and hepatic stellate cells. 

 


About International Stem Cell Corporation


International Stem Cell Corporation is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products.  ISCO’s core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs).  hpSCs avoid ethical issues associated with the use or destruction of viable human embryos.  ISCO scientists have created the first parthenogenetic, homozygous stem cell line that can be a source of therapeutic cells for hundreds of millions of individuals of differing genders, ages and racial background with minimal immune rejection after transplantation. hpSCs offer the potential to create the first true stem cell bank, UniStemCell. ISCO also produces and markets specialized cells and growth media for therapeutic research worldwide through its subsidiary Lifeline Cell Technology (www.lifelinecelltech.com), and stem cell-based skin care products through its subsidiary Lifeline Skin Care (www.lifelineskincare.com). More information is available at www.internationalstemcell.com.


To subscribe to receive ongoing corporate communications, please click on the following link: http://www.b2i.us/irpass.asp?BzID=1468&to=ea&s=0


To like our Facebook page or follow us on Twitter for company updates and industry related news, visit: www.facebook.com/InternationalStemCellCorporation and www.twitter.com/intlstemcell




Safe harbor statement 


Statements pertaining to anticipated developments, expected results of clinical studies, progress of research and development, and other opportunities for the company and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements. Any statements that are not historical fact (including, but not limited to statements that contain words such as “will,” “believes,” “plans,” “anticipates,” “expects,” “estimates,”) should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, risks inherent in the development and/or commercialization of potential products, regulatory approvals, need and ability to obtain future capital, application of capital resources among competing uses, and maintenance of intellectual property rights. Actual results may differ materially from the results anticipated in these forward-looking statements and as such should be evaluated together with the many uncertainties that affect the company’s business, particularly those mentioned in the cautionary statements found in the company’s Securities and Exchange Commission filings. The company disclaims any intent or obligation to update forward-looking statements.




International Stem Cell Corporation and Subsidiaries


Condensed Consolidated Balance Sheets


(in thousands, except share data)


 


 

 

June 30,

 

 

December 31,

 

 

 

2018

 

 

2017

 

Assets

 

(Unaudited)

 

 

 

 

 

Cash

 

$

477

 

 

$

304

 

Accounts receivable, net of allowance for doubtful accounts of $12

 

 

1,614

 

 

 

465

 

Inventory, net

 

 

1,682

 

 

 

1,307

 

Prepaid expenses and other current assets

 

 

567

 

 

 

779

 

Total current assets

 

 

4,340

 

 

 

2,855

 

Non-current inventory

 

 

718

 

 

 

692

 

Property and equipment, net

 

 

384

 

 

 

321

 

Intangible assets, net

 

 

2,910

 

 

 

2,922

 

Deposits and other assets

 

 

64

 

 

 

74

 

Total assets

 

$

8,416

 

 

$

6,864

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

 

 

 

Accounts payable

 

$

1,817

 

 

$

830

 

Accrued liabilities

 

 

819

 

 

 

607

 

Related party payable

 

 

1,108

 

 

 

 

Advances

 

 

250

 

 

 

250

 

Fair value of warrant liability

 

 

2,779

 

 

 

3,113

 

Total current liabilities

 

 

6,773

 

 

 

4,800

 

Commitments and contingencies

 

 

 

 

 

 

 

 

Stockholders’ Equity

 

 

 

 

 

 

 

 

Series B Convertible Preferred stock, $0.001 par value, 5,000,000 shares authorized, 250,000


   issued and outstanding, with liquidation preferences of $402 and $396 at June 30, 2018


   and December 31, 2017, respectively

 

 

 

 

 

 

Series D Convertible Preferred stock, $0.001 par value, 50 shares authorized, 43 issued and


   outstanding, with liquidation preference of $4,320

 

 

 

 

 

 

Series G Convertible Preferred stock, $0.001 par value, 5,000,000 shares authorized,


   issued and outstanding, with liquidation preference of $5,000

 

 

5

 

 

 

5

 

Series I-1 Convertible Preferred stock, $0.001 par value, 2,000 shares authorized, 1,094 and


   1,304 issued and outstanding, with liquidation preferences of $1,094 and $1,304 at


   June 30, 2018 and December 31, 2017, respectively

 

 

 

 

 

 

Series I-2 Convertible Preferred stock, $0.001 par value, 4,310 shares authorized,


   issued and outstanding with liquidation preference of $4,310

 

 

 

 

 

 

Common stock, $0.001 par value, 120,000,000 shares authorized, 6,295,888 and 6,057,132


  shares issued and outstanding at June 30, 2018 and December 31, 2017, respectively

 

 

6

 

 

 

6

 

Additional paid-in capital

 

 

107,388

 

 

 

106,585

 

Accumulated deficit

 

 

(105,756

)

 

 

(104,532

)

Total stockholders’ equity

 

 

1,643

 

 

 

2,064

 

Total liabilities and stockholders’ equity

 

$

8,416

 

 

$

6,864

 

                 


 


 


 


 




 


International Stem Cell Corporation and Subsidiaries


Condensed Consolidated Statements of Operations


(in thousands, except per share data)


(Unaudited)


 


 

Three Months Ended

 

 

Six Months Ended

 

 

June 30,

 

 

June 30,

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product sales

$

3,038

 

 

$

1,762

 

 

$

5,671

 

 

$

3,767

 

Total revenues

 

3,038

 

 

 

1,762

 

 

 

5,671

 

 

 

3,767

 

Expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cost of sales

 

1,095

 

 

 

471

 

 

 

1,920

 

 

 

1,024

 

Research and development

 

452

 

 

 

739

 

 

 

1,263

 

 

 

1,384

 

Selling and marketing

 

624

 

 

 

557

 

 

 

1,332

 

 

 

1,133

 

General and administrative

 

1,233

 

 

 

997

 

 

 

2,707

 

 

 

2,274

 

Total expenses

 

3,404

 

 

 

2,764

 

 

 

7,222

 

 

 

5,815

 

Loss from operations

 

(366

)

 

 

(1,002

)

 

 

(1,551

)

 

 

(2,048

)

Other income (expense)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Change in fair value of warrant liability

 

(21

)

 

 

1,584

 

 

 

334

 

 

 

(448

)

Interest expense

 

(7

)

 

 

(14

)

 

 

(9

)

 

 

(20

)

Miscellaneous income

 

1

 

 

 

 

 

 

2

 

 

 

 

Total other income (expense)

 

(27

)

 

 

1,570

 

 

 

327

 

 

 

(468

)

Income (loss) before income taxes

 

(393

)

 

 

568

 

 

 

(1,224

)

 

 

(2,516

)

Provision for income taxes

 

 

 

 

 

 

 

 

 

Net income (loss)

$

(393

)

 

$

568

 

 

$

(1,224

)

 

$

(2,516

)

Net income (loss) applicable to common stockholders

$

(393

)

 

$

568

 

 

$

(1,224

)

 

$

(2,516

)

Net income (loss) per common share-basic

$

(0.06

)

 

$

0.14

 

 

$

(0.20

)

 

$

(0.63

)

Net loss per common share-diluted

$

(0.06

)

 

$

(0.25

)

 

$

(0.20

)

 

$

(0.63

)

Weighted average shares-basic

 

6,225

 

 

 

3,996

 

 

 

6,181

 

 

 

3,974

 

Weighted average shares-diluted

 

6,225

 

 

 

4,017

 

 

 

6,181

 

 

 

3,974

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

                               


 




Contacts:


International Stem Cell Corporation
Russell Kern, PhD
Executive Vice President, CSO


Phone: 760-940-6383
Email: ir@intlstemcell.com

https://ih.advfn.com/p.php?pid=nmona&article=78077507

Halitron, Inc. (HAON) 31% Quarterly Growth to $474,000 Q2 Sales $83,000 Net Income

Halitron, Inc. (HAON) 31% Quarterly Growth to $474,000 Q2 Sales $83,000 Net Income

Halitron is forecasting 4 million in annual sales through its recently announced merger

Miami, FL — August 15, 2018 — InvestorsHub NewsWire — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Halitron, Inc. (OTC Pink: HAON).

Halitron (OTC Pink: HAON) just announced its financial results for the quarter ending June 30, 2018.

HAON may not be at these levels much longer.

See the Press Release and more on Halitron, Inc. (OTC Pink: HAON) at EmergingGrowth.com
http://emerginggrowth.com/?s=haon

The recently merged Retailiom brands have generated 474,825 in gross sales and realized net income of $83,718 for Q2, 2018, pre-merger, and before recurring charges.

Management is forecasting that sales of Retailiom post-merger will grow over 200% over the next twelve months.

Gross Profit remains consistent at 68%, overhead decreased as planned by $11,854 over the first quarter, and a one-time charge as it relates to the relocation totaled $27,905.
Below are detailed financial and operational updates:

— Sales were $474,825 in Q2, 2018, a 31.5% increase over the previous quarter.
— Direct Gross Margins for the portfolio manufacturing company were 68.3% for the quarter.
— A one-time charge of $27,905 was incurred directly due to the successful relocation Hopp assets to a lower-cost Connecticut facility.  The relocation was completed by May 1st, 2018.
— Cash Flows remain tight due to operating costs for the public company (Cash – $12,925) as well as debt financing charges, early customer payment discounts, and paying down old debts from the acquisition target.

Also recently Halitron, Inc. (OTC Pink: HAON) announced the merger of two acquisition brands resulting in “Retailiom” which, with the current customer contact list from both acquired entities of 111,235, is anticipated to add $4 million annually to Halitron’s already growing sales, which have been coming in at almost $400,000.00 per quarter before this merger. 

At the end of Q1 2018, Halitron’s portfolio company, Hopp Companies, Inc. had already realized a $61,000 profit for that quarter alone.

Retailiom alone, is expected to grow sales of Halitron, by over 200% over the next calendar year.

During fiscal years 2016 and 2017 respectively, HAON acquired the assets of a print-based point of purchase product businesses CinchSigns and the Hop Companies, Inc.  and has setup the infrastructure in Newtown, Connecticut to merge the assets of the two acquisitions into what is currently known as Retailiom.

Retailiom’s differentiating point in the market place is its ability to produce custom orders within 24-to-48 hours on product lines that are not readily available at competitors, like Staples, or Uline. Whether it’s a custom size, shape, color, or marketing message, Retailiom can meet the needs and timing of a critical retail marketing campaign.  Our products keep retail shelves neat, clean, and well-organized saving retailers time and money from a maintenance standpoint and increasing sales from a highly visible product position perspective.

Staples was purchased in September of 2017 for $6.9 billion.

Could Halitron be next?
Halitron (OTC Pink: HAON) also recently announced that its portfolio company, Hopp Companies, won a project with a major national retailer with over 425 retail stores.

Management is forecasting that the new project, which has already begun to ship, will have a projected positive impact on sales and gross margins for the fiscal year 2018. The product is a new supply product line for retail shelving that is internally manufactured.

Due to the competitive nature of the industry, Management has elected to keep the account name and any product line descriptions confidential, but can report that to most families, its new retail account is a household name.

Highlights from Halitron, Inc.’s (OTC Pink: HAON) previous Press Release:
 

  • No Reverse Split Planned.As previously communicated July 11, 2017, Management does not anticipate a reverse split of the stock to achieve the increased share objective but rather is forecasting for increased sales along with future accretive acquisitions whereby the cash flow from operations can be utilized to buy the shares back in the open market.
  • Audit and Up List to OTCQB. Halitron has re-engaged Freidman LLP to complete the 2017 audit, which is one of the qualifying factors to up list to the OTCQB exchange. Friedman was previously engaged to provide audit work for the period ending September 30, 2016 and will continue to finalize the project through September 30, 2017 over the coming months. Management will be adding another accounting intern to help support the growing business as well as focus on completing the audit for the period ending September 30, 2017.
  • Share Buy Back. Another requirement for the up list is a share price of $0.01 or higher and the Company, as previously announced, is currently engaged in a share buyback program to help support increased share price. Management is forecasting increased purchases quarter-over-quarter based on projected increasing cash flows, as the New York facility is closed, and the Company reaps the benefits of reduced overhead. Forecasted increasing sales from the new product launch and cross-selling initiatives will also have a positive impact on this project.
  • Sales have increased to approximately $407K in Q4, 2017, which represents 150% over approximately $163K for Q3 3017. There were no sales for 2016 to compare, as the strategic acquisition is now the foundation for the team to build on.

According to OTC Markets, the current market cap of Halitron, Inc. (OTC Pink: HAON) is approximately $2.1 million and as such, its shares can have a dramatic upside.

HAON may not be at these levels much longer.

See the Press Release and more on Halitron, Inc. (OTC Pink: HAON) at EmergingGrowth.com
http://emerginggrowth.com/?s=haon

Other Companies in the news and featured on EmergingGrowth.com

AirTrona International, Inc.
Stop sign company, AirTrona International, Inc. (OTC: ARTR) popped yesterday 133% on no news, and no OTC disclosure.  Trading in the stock has been dormant for as long as the eye can see, however on Tuesday’s close, shares traded over 77 million shares and rose to unprecedented heights.  Somebody was in the know.  With no new information in the market, the gains will be short lived. 

Have a look at Halitron, Inc.’s (OTC Pink: HAON) who just announced that it expects $4 million in sales from its recent merger.

Spectrum Global Solutions, Inc.
Spectrum Global Solutions, Inc. (OTC Pink: SGSI) on the other hand, has a small following and shares popped about 50% yesterday on news of new contract awards. The contracts are not the only thing that’s up with the company however, the outstanding share count is up 400% from 117 million to 445 million in the last twelve months.  Any potential gains are being eaten away by the issuance of more shares.

ReShape Lifesciences, Inc.
ReShape Lifesciences, Inc. (NASDAQ: RSLS) have been on a freefall from $22.00 since its earnings announcement of April 2, 2008. Yesterday was just more of the same as shares fell another 6% to .12 per share.  Earnings were announced yesterday after the close. How long do you think it will be before the company is forced to reverse to stay on NASDAQ? – If they choose to do so?

Have a look at Halitron, Inc. (OTC Pink: HAON).  Sales are increasing quarterly, and a recent merger is expected to add about $4 million in additional revenue over the next 12 months.

About EmergingGrowth.com
EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies.  Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization.  We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth.  Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community.  Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space. 

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. Full details about which can be found in our full disclosure, which can be found here, http://www.emerginggrowth.com/disclosure-4266/. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

CONTACT:
Company: EmergingGrowth.com – http://www.EmergingGrowth.com
Contact Email: info@EmergingGrowth.com
SOURCE: EmergingGrowth.com
 

https://ih.advfn.com/p.php?pid=nmona&article=78077410

Sixty Six Oilfield Services, Inc. announces Second Quarter 2018 Performance

 


Sixty Six Oilfield Services, Inc. announces Second Quarter 2018 Performance




 OKLAHOMA CITY, OK. — August 14, 2018 — InvestorsHub NewsWire — SIXTY SIX OILFIELD SERVICES, INC. (OTCBB: SSOF), announces Second Quarter Net Revenue of $176K on Gross Sales of $2.4M for the period ended June 30, 2018. Compared to the same period in 2017, the Company achieved quarter over quarter improvements of approximately 26% in gross sales, but a decline of 80%in net revenue. The Company‘s net margins decreased from 28% to 6% which reflected a change in the product mix for the quarter in which more new and used drilling pipe was sold which had higher procurement and refurbishment costs. .


 Dave T. Ho, President and Chief Executive Officer said “During the second quarter of the year we continue to work diligently to provide a quality product to the ever challenging demands of the drilling sector. Quality used drilling pipe supplies have tightened and this will continue to impact the Company’s overall profit margin if more new pipe is sold versus existing used inventory.. We feel that the oil industry in the U.S. will further strengthen which helps us to grow with the industry and one of the key reasons behind our recent acquisition of Five Star Rig and Supply.


  


About Sixty Six Oilfield Services, Inc.


Sixty Six Oilfield Services is now a third-generation heavy oil field equipment company founded in Oklahoma in 1959. Subsequent to the period ending June 30, 2018, the Company has completed the exchange with Fluid End Sales doing business as Five Star Rig and Supply which was established as a family owned business in 1984. The Company will continue to focus on supplying the oil industry with custom drilling rigs, heavy-weight drill pipe, drill collars, pup joints, pony collars, handling tools, tubing, casing, blow-out preventers, engines, compressors and other select equipment to customers world-wide through its facilities in Oklahoma City, Germany and Dubai. The Company’s services include the sale of new equipment, sale of refurbished and certified used equipment, as well as rental of oilfield equipment.


 


SAFE HARBOR AND INFORMATIONAL STATEMENT
This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of among other things: (i) the Company’s financing plans; (ii) trends affecting the Company’s financial condition or results of operations; (iii) the Company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may”, “would”, “will”, “expect”, “estimate”, “anticipate”, “believe”, “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the Company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the Company’s reports filed with the SEC. The Company is not eligible to rely on the safe harbor provided by Section 21E(c) of the Exchange Act because it is not subject to filing periodic reports under Sections 13 or 15(d) of the Exchange Act.


 


For more information, contact:
info@66oilfield.com
405.735.6666
855. DRL.PIPE (375-7473)


www.sixtysixoilfield.com


 


Only information that is publicly available will be provided.


 


 

https://ih.advfn.com/p.php?pid=nmona&article=78074274

Cannabis Strategic Ventures, Inc. Begins Production of Cannabis Filtration Device, Halo Filters

Cannabis Strategic Ventures, Inc. Begins Production of Cannabis Filtration Device, Halo Filters




Los Angeles, CA — August 14, 2018 — InvestorsHub NewsWire — Pure Applied Sciences, a wholly own subsidiary of Cannabis Strategic Ventures, Inc. (OTC: NUGS), begins production of Halo Filters. Halo Filters is the company’s patent pending, cannabis smoke filtration pre-roll cone. It is based on an internally developed filtering technology that utilizes ultra-high quality fibers and proprietary manufacturing methodologies. Halo Filters reduces the harsh taste in cannabis smoke and reduces the levels of harmful chemicals, heavy metals and other toxins, while maintaining optimum taste and cannabinoid levels.

Given that cannabis smoke can contain up to eight times the cyanide, three times the ammonia, and two times the nitrous oxide compared to tobacco smoke, Halo Filters was designed to address consumers’ growing concerns regarding the cannabis smoke’s potential harmful effects which may result in significant health issues.

“We’re extremely pleased with the progress of Halo Filters and excited for the upcoming product launch. Our teams have been working very hard to get the product to market,” commented Cannabis Strategic CEO, Simon Yu. “Consumers will soon be able to use Halo Filters and enjoy cannabis in the safest possible manner by having potential negative health effects minimized.” 

Halo Filters is a non-cannabis product, making it available for national and worldwide distribution. Worldwide pre-rolled sales are estimated to reach around $475 million. Halo Filter is scheduled to ship later this summer.

About Cannabis Strategic Ventures
 
Cannabis Strategic Ventures is based in Los Angeles and is focused on supporting entrepreneurial growth within the fast-growing legal cannabis sector. The Company, recently completed a name and symbol change from Cascade Energy, Inc. Cannabis Strategic Ventures offers outsourced personnel solutions that are tailor-made to match the growth dynamics of cannabis cultivators, manufacturers, dispensaries, and other cannabis marketplace participants. Cannabis Strategic Ventures is publicly traded on the U.S. Over the Counter Market with the stock symbol NUGS.
 
FORWARD-LOOKING STATEMENTS: This release contains “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements also may be included in other publicly available documents issued by the Company and in oral statements made by our officers and representatives from time to time. These forward-looking statements are intended to provide management’s current expectations or plans for our future operating and financial performance, based on assumptions currently believed to be valid. They can be identified by the use of words such as “anticipate,” “intend,” “plan,” “goal,” “seek,” “believe,” “project,” “estimate,” “expect,” “strategy,” “future,” “likely,” “may,” “should,” “would,” “could,” “will” and other words of similar meaning in connection with a discussion of future operating or financial performance.  Examples of forward-looking statements include, among others, statements relating to future sales, earnings, cash flows, results of operations, uses of cash and other measures of financial performance  Because forward-looking statements relate to the future, they are subject to inherent risks, uncertainties and other factors that may cause the Company’s actual results and financial condition to differ materially from those expressed or implied in the forward-looking statements. Such risks, uncertainties and other factors include, among others such as, but not limited to economic conditions, changes in the laws or regulations, demand for products and services of the company, the effects of competition and other factors that could cause actual results to differ materially from those projected or represented in the forward-looking statements.
 
Any forward-looking information provided in this release should be considered with these factors in mind. We assume no obligation to update any forward-looking statements contained in this report.
 

 

https://ih.advfn.com/p.php?pid=nmona&article=78068976

Progressive Care Inc. Reports Largest Six-Month Revenue Period in Company History in Q2 2018 Financial Filing

Progressive Care Inc. Reports Largest Six-Month Revenue Period in Company History in Q2 2018 Financial Filing

Miami, FL — August 14, 2018 — InvestorsHub NewsWire —  Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today announced financial results for the quarter ending June 30, 2018, and provided an overview of recent operational highlights along with updates on the Company’s strategies.

Progressive Care dispensed more than 67,000 prescriptions in Q2 2018, a 21.45% increase over Q2 2017, and 133,000 prescriptions for the six-month period ending June 30, a 23% increase over the same period in 2017. Pharmacy revenue for the six-month period ending June 30, 2018, was approximately $10.3 million, the largest six-month period in the Company’s history and an increase of 3.41%. Progressive Care’s total assets were $3,503,769 as of June 30, 2018, compared to $2,447,865 as of June 30, 2017 an increase of 43.13%. The Company continues to generate positive cash flow from its operations, with positive operational cash flow of approximately $69,000 for the six-month period ending June 30, 2018.

Progressive Care also reported raising over $1.4 million for 340B charitable organizations during Q2 2018, and $2.7 million total for the six-month period ending June 30, 2018. The Company’s total reported revenue included approximately $125,000 in fees earned on dispensing prescription medications to patients under 340B programs managed by two non-profit healthcare organizations in Florida. The Company expects expanded revenue growth through the signing of two new 340B contracts in July 2018. The contracts with Hope and Help Center of Central Florida and Care 4 U Management will begin on Oct. 1, 2018.

“We are proud to announce another quarter of significant growth compared to last year,” said S. Parikh Mars, CEO of Progressive Care Inc. “During this quarter, we completed our acquisition of Touchpoint Rx, continued developing our healthcare technological offering with the introduction of the PharmCo Smart-Pack Pouch Packaging system and the development of our own proprietary tele-pharmacy software called Tele-PharmCo.”

Mars continued: “Finally, through the launch of our alternative pain management therapies, we were able to begin diversifying Progressive Care’s suite of services and further position ourselves as a preferred online provider of healthcare resources for patients, physicians and providers. We hope that through these efforts, Progressive Care will be able to continue delivering increased value to our shareholders.”

Progressive Care anticipates that future growth will be driven by continued expansion into new market territories, concentrated efforts toward developing its compliance and adherence services provided to medical providers, and enhancement of technological opportunities that boost loyalty and customer satisfaction. Areas of current development include market penetration of Palm Beach and Martin Counties through the acquisition of Touchpoint Rx, LLC; the development of its Tele-PharmCo platform for its wholly owned subsidiary, PharmCo, LLC; the development and deployment of its online prescription management solution; and implementation of MTM protocols.

 

SECOND QUARTER 2018 HIGHLIGHTS

During the second quarter of 2018, Progressive Care Inc. achieved the following milestones and significant events:

 

Reported record-breaking year-over-year sales and growth numbers

In Q2 2018, the Company reported a total of $10.3 million in revenue, the largest single six-month period in its history to date. Progressive Care also experienced increases in prescriptions filled, reporting a 21.45% increase compared to the same quarter in 2017. Progressive Cares pharmacy services revenue growth is a result of the Companys expanding breadth of services, manufacturer price increases, new drugs coming to market, new indications for existing drugs, volume growth with current clients, and addition of new customers due to its focus on higher patient engagement and clinical expertise.

The Company dispensed a total of 66,800 prescriptions in Q2 2018, a 21.45% increase over Q2 2017. Progressive Care’s total assets were $3,503,769 as of June 30, 2018, compared to $2,447,865 as of June 30, 2017 an increase of 43.13%.

 

Furthered growth and expansion plans through pharmacy acquisition

The Company executed a definitive agreement to purchase the Touchpoint Rx pharmacy in Palm Beach County. Under this agreement, PharmCo assumed all day-to-day management of the pharmacy, which included assumption of all revenue and expenses. The acquisition will facilitate the Company’s growth plans by decreasing the cost of servicing its delivery radius into Martin County, which includes Jupiter and Stuart, and will decrease costs of expansion and increase prescription dispensing efficiency.

Expansion of robot pharmacy machinery fleet

The Company purchased and installed a new Automated Pouch Packaging System for its Miami-Dade County PharmCo location. Progressive Care’s wholly-owned subsidiary, PharmCo, LLC, is one of the first in South Florida to offer this new packaging system PharmCo Smart-Pack that allows patients to receive customized dosage pouches according to their daily prescription needs.

 

Continued development of technology driven healthcare service options

The Company rolled out its online prescription management solution allowing PharmCo patients to visit www.pharmcopharmacy.com and access the company’s prescription management platform, making the prescription request process even easier. The web-based forms are user-friendly and fully integrated for easy processing and quick turn-around on new, transfer and refill prescriptions.

Additionally, the Company started the development of its own proprietary tele-pharmacy software, Tele-PharmCo, to digitally communicate with patients, physicians, pharmacists and caretakers across the world. This state-of-the-art multi-platform technology will be capable of running on kiosk, desktop and mobile devices. The move comes as part of Progressive Care’s overall effort to expand its current kiosk program.

 

Provided further education on alternative treatments to opioids

The Company launched a new program designed to educate patients and providers on treatment alternatives to opioids available through the company. The campaign is part of the Companys initiative to spread awareness of available alternative therapies that can improve a persons quality of life and, in many cases, prevent tragedy caused by opioid abuse and solve the nationwide epidemic.

 

Maintained steady investor relations activity

The Company actively communicated with its customers and shareholders through various investor announcements.

These efforts included:

         Acting to alleviate pressure caused by naked short positions in the Company’s stock. The Company contacted several broker/dealers, clearing firms and reached out to FINRA’s Division of Market Regulation about the problem naked shorting is causing in the market for the Company’s securities.

         Partnering with CMW Media as its public relations agency of record as part of Progressive Cares overall effort to expand marketing and communications activities for the company and all subsidiaries.

         Engagement with The Benchmark Company, LLC as a financial advisor as it moves forward with the process of re-registration with the U.S. Securities and Exchange Commission and pursuing a listing on a national securities exchange.

 

SECOND QUARTER 2018 FINANCIAL RESULTS

Net Revenue: For the six-month period ending June 30, 2018, Progressive Care showed net sales of $10,268,886, as compared to net sales of $9,930,422 for the six-month period that ended June 30, 2017, an increase of 3.41%.

Balance Sheet: Total Assets for the company were $3,503,769 as of June 30, 2018, compared to $2,447,865 as of June 30, 2017, an increase of 43.13%.

Net Cash Provided by Operating Activities: Operating cash flow increased from ($272,769) to $69,444 year-over-year, which is an increase of over 125.45%.

 

For more information about Progressive Care, please visit the companys website.

 

Connect and stay in touch with us on social media:

 

Progressive Care Inc.

https://www.facebook.com/ProgressiveCareUS/

https://twitter.com/ProgressCareUS

 

PharmCo, LLC

https://www.facebook.com/pharmcorx/

https://twitter.com/PharmCoRx

 

About Progressive Care Inc.

Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.

 

Cautionary Statement Regarding Forward Looking Statements

Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Companys expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intendand expectand similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.

 

Public Relations Contact:

Tory Patterson, CMW Media

Tory@cmwmedia.com

www.cmwmedia.com

 

Investor Relations Contact:

Armen Karapetyan, Progressive Care

Senior Advisor Business Development

Armen@progressivecareus.com

www.progressivecareus.com

www.pharmcopharmacy.com

 

 

https://ih.advfn.com/p.php?pid=nmona&article=78068633

Wuhan General Group/SDT Holdings (OTCBB: WUHN) Reports 140% Revenue Increase in its Consulting Division


Wuhan General Group/SDT Holdings (OTCBB: WUHN) Reports 140% Revenue Increase in its Consulting Division


MONTREAL, QC — August, 14, 2018 — InvestorsHub NewsWire — Wuhan General Group (China), Inc./ SDT Holdings, Inc.  (OTC PINK: WUHN) (the “Company”), an industrial technology company focused on creating industrial batteries and electric equipment for the mining, construction and agricultural industries announced today that for the period ended June 30, 2018, gross revenue from its consulting services division increased 140 percent as compared to the same period in the previous year. Gross revenue for the period ended June 30, 2018 was $154,000 as compared to $64,000 for the same period in the previous year. In addition, the company has begun to see positive cash flow in the second quarter of 2018.

“Our consulting-services team achieved a strong six months characterized by solid revenue growth and major core development, while navigating this challenging phase of going public,” said CEO Ramy Kamaneh.

Mr. Kamaneh continued, “As many industries move away from gas and diesel power and adopt electric vehicles and other equipment, we expect to see a pattern of high double digit revenue growth going forward. Our deep understanding of the specifications for these industrial batteries along with the in-field operations of various industries allows us to have a competitive advantage when we are asked to provide a solution for some of North America’s largest companies.”

About SDT Holdings, Inc.

SDT Holdings, Inc. is a Nevada corporation  engaged in the research, development and manufacturing of industrial battery technologies and electric Material handling equipment (eMHE) to assist the mining, construction and agricultural industries in eliminating greenhouse gas (GHG) emissions by moving from diesel power to a battery-powered energy source. SDT’s deep understanding of battery chemistry and the in-field operations for industries such as the underground mining industry, gives it a competitive advantage to become a leader in the development of this space as well as in assisting these industries in their adoption to battery powered material handling equipment.

By complementing its industrial batteries and eMHE with predictive maintenance using artificial intelligence and hardware (Internet of things), SDT can effectively manage and coordinate a full-scale battery-powered operation and charging infrastructure 24-7 at some of the most remote locations in the world.

SDT Holdings, Inc. is also  exploring the research and application of blockchain technologies to the mining, agriculture and construction industries.

SDT Holdings, Inc

Publicly traded company (OTC Pink: WUHN)

Website: www.sdtholdings.com

For further information contact:
Contact: Bruce Haase – Public Relations

Phone: (514) 928-7368 Ext 6

E-mail: info@sdtholdings.com

 

Forward-Looking Statements
Safe Harbour Statement – In addition to historical information, this press release may contain statements that constitute forward-looking statements within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release include the intent, belief, or expectations of the Company and members of its management team with respect to the Company’s future business operations and the assumptions upon which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance, and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Factors that could cause these differences include, but are not limited to, failure to complete anticipated sales under negotiations, lack of revenue growth, client discontinuances, failure to realize improvements in performance, efficiency and profitability, and adverse developments with respect to litigation or increased litigation costs, the operation or performance of the Company’s business units or the market price of its common stock. Additional factors that would cause actual results to differ materially from those contemplated within this press release can also be found on the Company’s website. The Company disclaims any responsibility to update any forward-looking statements.

Source: Wuhan General Group (China), Inc

 

https://ih.advfn.com/p.php?pid=nmona&article=78068637

AUXLY ANNOUNCES PRODUCT STRATEGY UPDATE AND WORLD-CLASS ADDITIONS TO DOSECANN’S MANAGEMENT TEAM

AUXLY ANNOUNCES PRODUCT STRATEGY UPDATE AND WORLD-CLASS ADDITIONS TO DOSECANN‘S MANAGEMENT TEAM

 


Vancouver, BC — August 14, 2018 — InvestorsHub NewsWire —  Auxly Cannabis Group Inc. (TSX.V – XLY) (“Auxly” or the “Company“) is pleased to provide an update on the product strategy of the Company’s wholly owned subsidiary, Dosecann Inc. (“Dosecann”), as well as a number of strategic additions to the management team of Dosecann.

Dosecann, Auxly’s cornerstone midstream asset that is Canada’s largest cannabis specific “Licensed Dealer”, is positioned to play a significant role as a leading research, product development, extraction, formulation and consumer packaged goods manufacturing center in the Canadian cannabis industry with its 42,000 square foot purpose-built facility in Charlottetown, PEI.

As previously announced, Dosecann has successfully obtained a Dealer’s Licence for Controlled Drugs and Substances (the “Licence”) from Health Canada and has commenced operations related to the creation of value-added cannabis products, as permitted by the Licence and applicable laws. Dosecann has further subdivided its cannabis activities into two segments, Medical Products and Consumer Packaged Goods.

The Medical Products segment, led by Dr. Christina Woollard and Dr. Bob Chapman, is focused primarily on research and development of new value-added cannabis products for sale to domestic and global medical cannabis and wellness markets. Part of this segment’s activities will include observational studies and clinical trials to validate the efficacy of new cannabis formulations and intellectual property.  It should be noted that, while current regulations do not allow for the creation of Natural Health Products containing cannabis, the Medical Products segment of Dosecann’s business will also focus on addressing market demand for wellness products containing cannabinoids through the research and development of such products within the parameters of applicable legislation.

The Consumer Packaged Goods segment, led by Mr. Peter Crooks and Dr. Bob Chapman, is focused on the creation of novel consumer packaged products for the medical and non-medical cannabis markets. Initially, this segment of Dosecann’s business will be focused on the creation and manufacturing of cannabis edible and cannabis concentrate products for sale within Canada in anticipation of Health Canada permitting the sale of such products in 2019.

The Company is also excited to present Dosecann’s world-class management team as follows:

Greg Boone
(Founder & Chief Executive Officer)

Mr. Boone is a seasoned entrepreneur with over 20 years of experience in the Executive Search and Management consulting field through his company HEC GROUP. He specializes in building high performance teams for his clients in the automotive, food, pharma and chemical industries. For the past 5 years, Mr. Boone has applied his talents to the rapidly emerging medical Cannabis industry as an investor and trusted advisor to companies throughout the world looking to enter this space. Mr. Boone founded Dosecann with the primary goal of bringing the best cannabis innovations to domestic and international consumers across medical, wellness and recreational market segments.

Dr. Christina Woollard
(Chief Scientific Officer)

Dr. Woollard has more than 20 years’ experience in the pharmaceutical development industry, across big and small pharma. Prior to joining Dosecann, Dr. Woollard worked as a Formulation Scientist at Pfizer for 4 years and then joined GW Pharmaceuticals, a British biopharmaceutical company. She spent 16 years with GW Pharmaceuticals managing the Product Development team and working on multiple cannabinoid projects including Sativex, Epidiolex, injectables, solid oral dosage forms and THCV products. Dr. Woollard received her degree in Pharmacy from the University of Wales, Cardiff, followed by a PhD, studying the use of liposomes to deliver gene therapy to the lung.

Peter Crooks
(Chief of Product Innovation)

Mr. Crooks brings more than 20 years of senior leadership experience in product and brand development across food & beverage, natural health products, medical devices and pharmaceuticals. Most recently as the Executive Director of Canada’s Smartest Kitchen (Canada’s leading food development laboratory) for which Mr. Crooks was recognized in 2017 as one of Atlantic Canada’s Top 50 CEOs, Mr. Crooks successfully led a multi-disciplinary team of chefs, food scientists, marketing professionals and product developers to become Canada’s leading food product development center. In his career, he has overseen the development of over 2,100 products and raised more than $160M to support product innovation and commercialization. He also has been involved in the conceptualization, design and build of three Maritime-based innovation and applied research centers and currently advises several Federal departments on the future of food and innovation.

Dr. Bob Chapman 
(Chief Operating Officer)

Dr. Chapman has been applying his broad practical experience in organic and analytical chemistry for the past nineteen years to solve problems of industrial relevance.  Most recently, Dr. Chapman was a Principal Research Officer with the National Research Council Canada (“NRC”) Aquatic & Crop Resource Development Research Centre based out of Charlottetown, PEI. With the NRC, Dr. Chapman was responsible for leading a national program and strategic projects focused on the development of Natural Health Products and functional ingredients with private sector companies. In particular, he was responsible for leading strategic projects that aim to develop new functional ingredients based on nutritional oils and plant-based proteins which led to research on cannabinoid-based mixtures. Prior to the NRC, Dr. Chapman spent 6 years working as a Senior Scientist for two venture capital funded bioscience startup companies in San Francisco, California.  Dr. Chapman is an Adjunct Professor with the Chemistry Department at the University of Prince Edward Island, the Vice-President of the NHP Research Society, a member of several international standards groups including ASTM D37 committee on cannabis serving as the recording secretary for the processing and handling subcommittee.  For NRC ACRD’s research center, he served on national advisory committee’s supporting the standardization needs for the emerging cannabis industry to ensure quality and safety of cannabis supply.  Dr. Chapman is an active member of the Canada’s bioscience community serving on several boards and advisory boards He holds a Ph.D. in Organic Chemistry from the University of British Columbia, has published widely, holds several patents, and has presented at numerous scientific symposia.  Dr. Chapman is the recipient of many awards, including a postdoctoral fellowship from the Natural Sciences and Engineering Research Council of Canada (NSERC) tenured in the Department of Chemistry and Chemical Biology at Harvard University with Professor George Whitesides.

Allan Arsenault
(Director of Operations)

Mr. Arsenault has more than 17 years of senior management experience within the food industry. He has extensive experience in GMP, HACCP, budgeting, production planning, human resources, materials management, equipment planning, training, auditing, and facility management. He has experience with CFIA, FDA, and SQF audits and has managed facilities that met and exceeded government food safety standards and has led plants to be industry leaders in food safety. Allan has a business degree in Management and a degree in Socio-economics from UPEI in addition to an engineering certificate from Holland College.

Sandra LeClair
(Director of Quality)

Ms. LeClair has been working within the PEI scientific community for over 20 years, with a wide range of experience in multiple roles in academia, government, and private industry. For the past 6 years, she managed the Quality Control department in a GMP facility manufacturing animal vaccines that were distributed worldwide. Prior to this, Ms. LeClair spent 5 years as a Senior Scientist for a global animal health company, working on developing new and unique animal health products. Ms. LeClair graduated with honors from UNB with a Bachelor of Science, and proceeded to enroll in the Masters of Science program at UPEI, completing her Master’s thesis in 2000.

Jeremy Stiles
(Regulatory Affairs/GMP Consultant)

Mr. Stiles is an experienced quality professional in the pharmaceutical and life sciences industry.  With over 30 years’ experience as a leader in the public and private sector he has worked extensively to design, develop and implement quality and environmental management systems. He is well versed in a variety of quality assurance standards and the regulatory requirements associated with pharmaceutical filings such as CMC, DMF’s, NDA’s or ANDA’s. Prior to joining Dosecann, Mr. Stiles spent 20 years with BioVectra, most recently as Director, Quality Assurance and Regulatory Affairs. Mr. Stiles graduated from the University of London England with a Masters of Science in Environmental Management.

“On behalf of the Board of Directors and Management, it gives me great pleasure to congratulate Greg on building a world-class operation and to welcome the incredible team he has assembled at Dosecann to the Auxly Cannabis platform.” said Hugo Alves, President of Auxly. “Dosecann is the cornerstone asset in the midstream segment of our business and we feel strongly that the team that has been assembled and the product innovation and development strategy that Dosecann has developed distinguishes Auxly from its peers and puts us in a position to become one of the leading cannabis products companies in the world.  We are hugely excited to see these products come to life at Dosecann and offering consumers innovative quality products backed by research and science!”       

ON BEHALF OF THE BOARD
Chuck RificiChairman & CEO

About Auxly Cannabis Group Inc. (TSX.V: XLY)

Auxly Cannabis Group is a collective of entrepreneurs with a passion for the cannabis industry past, present and future. Our mandate is to facilitate growth for our partners by providing them with financial support and sharing our collective industry experience. Our partners all have different visions, voices and brand values, and all share a common goal—to build a world-class industry based on ethics, diversity, quality and innovation.

About Dosecann

Dosecann Inc. is a PEI-based Licensed Dealer applicant currently completing the buildout of a 42,000-square foot GMP compliant facility. Within the purpose-built facility, Dosecann intends to accommodate product development, extraction, formulation, filling and packaging. Dosecann is developing a suite of cannabis products across a variety of delivery methods for both domestic and international medical and adult use markets.

Investor Relations:

For more information about investing in Auxly Cannabis Group, please visit: http://www.auxly.com or contact our Investor Relations Team: 
Email: IR@auxly.com
Phone: 1-833-695-2414

Stay Connected: 

Follow up on Twitter @Auxlygroup

Media Enquiries (only): 

For media enquiries or to set up an interview please contact:
Sarah Bain, VP External Affairs 
Email: sarah@auxly.com 
Phone: 613.230.5869
Notice Regarding Forward Looking Information:

This news release contains certain “forward-looking information” within the meaning of applicable Canadian securities law. Forward-looking information is frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or information that certain events or conditions “may” or “will” occur. This information is only a prediction. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking information throughout this news release. Forward-looking information includes, but is not limited to: the proposed operation of Dosecann’s facility, future legislative and regulatory developments involving cannabis and cannabis products, the timing of proposed research and clinical trials, the timing and outcomes of regulatory or intellectual property decisions, the relevance of Dosecann’s proposed products, consumer preferences, political change, competition and other risks affecting the Company in particular and the cannabis industry generally.

A number of factors could cause actual results to differ materially from a conclusion, forecast or projection contained in the forward-looking information in this release including, but not limited to, whether: Dosecann is able to maintain its Licence; the Company is able to successfully manage the integration of Dosecann’s operations with its own; Dosecann can obtain all necessary governmental and regulatory permits and approvals for the operation of the facility and the development of its proposed products, and whether such permits and approvals can be obtained in a timely manner; the success of Dosecann’s research strategies, the applicability of the discoveries made therein, the successful and timely completion and uncertainties related to the regulatory process, the acceptance of future Dosecann product by consumer and medical professionals, and general economic, financial market, legislative, regulatory, competitive and political conditions in which the Company and Dosecann operate will remain the same. Additional risk factors are disclosed in the revised annual information form of the Company for the financial year ended December 31, 2017 dated May 24, 2018.

New factors emerge from time to time, and it is not possible for management to predict all of those factors or to assess in advance the impact of each such factor on the Company’s business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking information. The forward-looking information in this release is based on information currently available and what management believes are reasonable assumptions. Forward-looking information speaks only to such assumptions as of the date of this release. In addition, this release may contain forward-looking information attributed to third party industry sources, the accuracy of which has not been verified by the Company. The purpose of forward-looking information is to provide the reader with a description of management’s expectations, and such forward-looking information may not be appropriate for any other purpose. Readers should not place undue reliance on forward-looking information contained in this release.

The forward-looking information contained in this release is expressly qualified by the foregoing cautionary statements and is made as of the date of this release. Except as may be required by applicable securities laws, the Company does not undertake any obligation to publicly update or revise any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, whether as a result of new information, future events or results, or otherwise.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

https://ih.advfn.com/p.php?pid=nmona&article=78068635

Therapeutic Solutions International Reports Synergistic Enhancement of Ozone Therapy Efficacy in Prostate, Breast and Ovarian..

 Therapeutic Solutions International Reports Synergistic Enhancement of Ozone Therapy Efficacy in Prostate, Breast and Ovarian Cancer Cells by Pterostilbene

Clinical Stage Cancer Immunotherapy Biotechnology Company Files Patent Expanding Uses of its Pterostilbene Based Product Pipeline

Oceanside, CA — August 13, 2018 — InvestorsHub NewsWire — Therapeutics Solutions International, Inc., (OTC Markets: TSOI) announced today filing of a patent on recent data showing pterostilbene potently augments killing of breast cancer, prostate cancer, and ovarian cancer cells by ozone therapy.

The data are an extension of ongoing work at the Company seeking to identify means of enhancing the effects of pterostilbene administration for treatment of a variety of cancers, as well as enhancing the efficacy of existing cancer therapies.

Previously the Company has been granted United States Patent # 9,682,047 covering augmentation of immunotherapy efficacy using pterostilbene administration. Furthermore, the Company has developed NanoStilbene, a nanotechnology-based product that enhances optimal delivery of pterostilbene to tissue. In the current patent application, administration of ozone in conjunction with various concentrations of pterostilbene resulted in enhanced tumor cell killing, without killing of control, non-cancer cells.

“The ability of ozone gas to possess a selective ability to kill cancer cells compared to non-cancer cells has been known since the 1980 publication by Sweet et al in the prestigious peer-reviewed journal Science1. Furthermore, peer-reviewed studies have demonstrated that ozone therapy can enhance cancer-killing effects of chemotherapy2” said Timothy Dixon, President, and CEO of Therapeutic Solutions International. “By demonstrating potentiation of the cancer-killing effects of ozone therapy by pterostilbene, we anticipate initiating collaborations with international doctors studying the efficacy of this modality in the treatment of cancer.”

Therapeutic Solutions International has performed clinical pharmacokinetic studies using NanoStilbene to deliver pterostilbene. The concentrations of pterostilbene that are found in the blood 4 hours after oral administration of NanoStilbene are sufficient to enhance the cancer-killing effect of ozone therapy based on data presented in the patent application.

“Pterostilbene is known to kill cancer cells in part through increasing endoplasmic reticulum stress selectively in tumors and not in healthy cells3. Our hypothesis was that ozone therapy may alter endoplasmic reticulum-associated molecular pathways, and thus a synergistic effect may be observed” said Dr. James Veltmeyer, Chief Medical Officer of the Company. “By understanding molecular mechanisms of “alternative medicines” such as ozone therapy, we can identify ways of leveraging their effects and developing therapeutic approaches that have higher chances of success.”

“Numerous physicians internationally are using ozone therapy and other means of oxidative medicine to treat chronic illness. Although techniques such as autohemotherapy have a very strong safety record, little work is being conducted at elucidating mechanisms of action and identifying ways of integrating these approaches into conventional cancer care” said Dr. Juergen Winkler, Member of the Company’s Scientific Advisory Board and Medical Director of Quantum Functional Medicine. “The medical doctors and scientists at Therapeutic Solutions International are leading the way in developing scientific understanding for molecular mechanisms of alternative medical immunotherapies in an objective and rigorous manner. By combining alternative medicine with cutting edge science, I am eager to watch the proper clinical trial translation that TSOI has performed in taking these concepts from bench to bedside.”

About Therapeutic Solutions International, Inc.

Therapeutic Solutions International is focused on immune modulation for the treatment of several specific diseases. Immune modulation refers to the ability to upregulate (make more active) or downregulate (make less active) one’s immune system. The Company’s corporate website is www.therapeuticsolutionsint.com.

1 Sweet et al. Ozone selectively inhibits growth of human cancer cells. Science. 1980 Aug 22;209(4459):931-3. https://www.ncbi.nlm.nih.gov/pubmed/7403859

2 Zanker et al. In vitro synergistic activity of 5-fluorouracil with low-dose ozone against a chemoresistant tumor cell line and fresh human tumor cells. Chemotherapy. 1990;36(2):147-54. https://www.ncbi.nlm.nih.gov/pubmed/2311442

3 Papandreou et al. Plant stilbenes induce endoplasmic reticulum stress and their anti-cancer activity can be enhanced by inhibitors of autophagy. Exp Cell Res. 2015 Nov 15;339(1):147-53. https://www.ncbi.nlm.nih.gov/pubmed/26477823

Safe Harbor Statement

This release contains forward-looking statements that are based upon current expectations or beliefs, as well as a number of assumptions about future events. Although we believe that the expectations reflected in the forward-looking statements and the assumptions upon which they are based are reasonable, we can give no assurance that such expectations and assumptions will prove to have been correct. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “could,” “expect,” “anticipate,” “estimate,” “believe,” “intend,” or “project” or the negative of these words or other variations on these words or comparable terminology. The reader is cautioned not to put undue reliance on these forward-looking statements, as these statements are subject to numerous risk factors as set forth in our SEC filings. To the extent that statements in this press release are not strictly historical, including statements as to product launch timing, revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future collaboration agreements, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made.

CONTACT INFORMATION

https://ih.advfn.com/p.php?pid=nmona&article=78060284

CSE New Listing – Tree of Knowledge International Commences Trading on the CSE – Video News Alert on Investmentpitch.com

Vancouver, British Columbia — August 13, 2018 — InvestorsHub NewsWire — Tree of Knowledge International Corp. (CSE: TOKI) is the latest new listing on the Canadian Securities Exchange, having previously traded as Courtland Capital on the TSX Venture Exchange.

The company produces and sells hemp-based cannabidiol or CBD products in certain jurisdictions in the United States, as well as in Europe, South America, Australia and China.

 

Cannot view this video? Visit: 
http://www.investmentpitch.com/video/0_etyxyql9/Tree-of-Knowledge-International-Corp-CSETOKI-New-Listing

InvestmentPitch Media has produced a “video” which provides a brief overview of the company. If this link is not enabled, please visit www.InvestmentPitch.com and enter “Tree of Knowledge” in the search box.

The company’s CBD product line contains EVR Premium Hemp Oil, which is derived from U.S. Department of Agriculture approved industrial hemp grown in the United States. Products include hemp oil, capsules, tinctures and balm.

The products are: ORGANICALLY GROWN, ORGANICALLY HANDLED, NON-GMO, VEGAN and GLUTEN-FREE and may be used in connection with the treatment of a number of ailments and for general wellness purposes.

The company places QR codes on all of its products so customers can view the third-party lab results for each specific product batch. Each Certificate of Analysis shows the amount of CBD in the product along with test results for the presence of pesticides, microbials and heavy metals to ensure the products are of the highest purity.

The company has appointed Vancouver-based Northbay Capital Partners Corp. as its strategic, financial and M & A advisor to help identify, evaluate and structure strategic transactions to maximize shareholder value. Please visit www.northbaycapitalpartners.com, or contact Rahim Rajwani at 604-376-8821.

For more information, please visit the company’s website www.evrcbd.com, contact Michael Caridi, Chairman and CEO, at 917-295-1374, or email michael@evrcbd.com.

About InvestmentPitch Media

InvestmentPitch Media leverages the power of video, which together with its extensive distribution, positions a company’s story ahead of the 1,000’s of companies seeking awareness and funding from the financial community. The company specializes in producing short videos based on significant news releases, research reports and other content of interest to investors.

CONTACT: 

InvestmentPitch Media 

Barry Morgan, CFO
bmorgan@investmentpitch.com

 https://ih.advfn.com/p.php?pid=nmona&article=78060276

GreenBox POS Acquires Sky Technologies, Begins Onboarding of Over a $1B Book of Business

 

 GreenBox POS Acquires Sky Technologies, Begins Onboarding of Over a $1B Book of Business

SAN DIEGO, CA. — August 13, 2018 — InvestorsHub NewsWire GreenBox POS, LLC  (USOTC: GRBX), (“GreenBox“, “the Company”) is pleased to announce the acquisition of Sky Mids Technologies (“Sky”), development and processing Corporation. Sky’s transactional platform specializes in robust and secure payments processing. The company has been utilizing GreenBox’s revolutionary payments system, QuickCard, as its main payments infrastructure for some time and the experience has been exceptional for both companies. The speed, accuracy, security, privacy and extendibility of QuickCard and its TrustGateway technology, as well as its inherent resistance to fraud, have been a great addition to Sky’s services and its clients’ experience. Additionally, GreenBox has had the opportunity to see how its system functions on a much larger scale and stress test its ability to improve efficiencies in an existing framework. Sky proved to be an excellent candidate with their large processing volumes, giving the Company opportunity to measure just how much more efficient their Blockchain powered solution can be. As expected, the results are astounding. The system is fraud-resistant and has measurably improved system efficiency over previous models.

Sky’s transactional book of business, Capable of processing over $1 Billion annually, will selectively be added to GreenBox’s infrastructure volume. The acquisition of Sky adds more than just volume to GreenBox POS business; The Company will also absorb Sky’s staff, consisting mostly of engineers, and a host of technology already developed under Sky, who is already familiar with the Quick Card system. This should make for both an easy transition and fast launch into additional joint capabilities.

Ken Haller, CEO of Sky, will be appointed to GreenBox’s Senior Vice President, Payment Systems, following the
acquisition.

“This is a great opportunity for both GreenBox and Sky,” said Ben Errez, Executive Vice President of GreenBox. “We have been working with Sky for a while now and are thoroughly impressed with their technology and capabilities. Their engineers are top notch and I am confident the synergy will continue to add to the plethora of new technologies we have brought, and will continue to bring, to market. GreenBox’s unparalleled infrastructure sets new and much higher expectations by both businesses and consumers. Following the Sky acquisition, we will be able to accelerate the pace by which the thousands of new business applications are processed, and the best selected to join our ecosystem and enjoy the benefits of our technology”.

About GreenBox POS, LLC:

GreenBox POS (“GRBX”) is a groundbreaking technology company that builds customized payment solutions for a multitude of industries. The company has developed the fastest and safest way to send and process money using Blockchain technology. The company was awarded 5 provisional patents for its technology. GreenBox POS develops the following main products: POS (Point of Sale software and hardware solutions); DEL (delivery app, APIs to POS and PAY); PAY (payment app, providing financial APIs to all other components); KIOSK (deposit, cash and E-wallet management). All products, services and custom hardware are available now from GRBX. GRBX is based in California with offices in Seattle, WA; Las Vegas, NV; Vancouver, BC, Canada; and HQ in San Diego, CA.

For more information, visit the company’s website athttps://www.GreenBoxPOS.com 

 

Forward-Looking Statements Disclaimer:

This release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. All forward-looking statements are inherently uncertain as they are based on current expectations and assumptions concerning future events or future performance of the company. Readers are cautioned not to place undue reliance on these forward-looking statements, which are only predictions and speak only as of the date hereof. In evaluating such statements, prospective investors should review carefully various risks and uncertainties identified in this release and matters set in the company’s SEC filings. These risks and uncertainties could cause the company’s actual results to differ materially from those indicated in the forward-looking statements.

 

Public Relations and Media Contact:

 GreenBox POS, LLC

www.GreenBoxPOS.com

Office: 619-930-5500

Info@GreenBoxPOS.com

 

 

 

https://ih.advfn.com/p.php?pid=nmona&article=78059922

Halitron, Inc. (HAON) Merger to Generate $4 million in Sales

Halitron, Inc. (HAON) Merger to Generate $4 million in Sales

Halitron is forecasting 4 million in annual sales through its recently announced merger

Miami, FL — August 13, 2018 — InvestorsHub NewsWire — EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on Halitron, Inc. (OTC Pink: HAON).

Halitron (OTC Pink: HAON) just announced the merger of two acquisition brands resulting in “Retailiom” which, with the current customer contact list from both acquired entities of 111,235, is anticipated to add $4 million annually to Halitron’s already growing sales, which have been coming in at almost $400,000.00 per quarter before this merger. 

At the end of Q1 2018, Halitron’s portfolio company, Hopp Companies, Inc. had already realized a $61,000 profit for that quarter alone.
Retailiom alone, is expected to grow sales of Halitron, by over 200% over the next calendar year.

During fiscal years 2016 and 2017 respectively, HAON acquired the assets of a print-based point of purchase product businesses CinchSigns and the Hop Companies, Inc.  and has setup the infrastructure in Newtown, Connecticut to merge the assets of the two acquisitions into what is currently known as Retailiom.

HAON may not be at these levels much longer.

See the Press Release and more on Halitron, Inc. (OTC Pink: HAON) at EmergingGrowth.com
http://emerginggrowth.com/?s=haon

Retailiom’s differentiating point in the market place is its ability to produce custom orders within 24-to-48 hours on product lines that are not readily available at competitors, like Staples, or Uline. Whether it’s a custom size, shape, color, or marketing message, Retailiom can meet the needs and timing of a critical retail marketing campaign.  Our products keep retail shelves neat, clean, and well-organized saving retailers time and money from a maintenance standpoint and increasing sales from a highly visible product position perspective.

Staples was purchased in September of 2017 for $6.9 billion.

Could Halitron be next?

Halitron, Inc. (OTC Pink: HAON) is expecting to release its Q2 operating results before the market open on August 15

Halitron, Inc Beats $350,000 Forecast for the First Quarter of 2018

  •  Sales were $361,000 in Q1, 2018, a period in which management relocated operations in New York to Connecticut facilities without a negative impact to shipments.
  •  Direct Gross Margins for the portfolio manufacturing company were 69.8% for the quarter.
  •  A one-time charge of $46,529 was incurred directly due to the successful relocation of Hopp assets to a lower-cost Connecticut facility.
  •  The combined cash balance at the end of the quarter totaled $61,280.
  •  Solid revenues, consistent margins, as well as the exit of our New Hyde Park, New York facility will reduce overhead costs and improve cash flows for the remainder of the year.

Halitron (OTC Pink: HAON) also recently announced that its portfolio company, Hopp Companies, won a project with a major national retailer with over 425 retail stores.

Management is forecasting that the new project, which has already begun to ship, will have a projected positive impact on sales and gross margins for the fiscal year 2018. The product is a new supply product line for retail shelving that is internally manufactured.

Due to the competitive nature of the industry, Management has elected to keep the account name and any product line descriptions confidential, but can report that to most families, its new retail account is a household name.

Highlights from Halitron, Inc.’s (OTC Pink: HAON) previous Press Release:

  • No Reverse Split Planned.As previously communicated July 11, 2017, Management does not anticipate a reverse split of the stock to achieve the increased share objective but rather is forecasting for increased sales along with future accretive acquisitions whereby the cash flow from operations can be utilized to buy the shares back in the open market.
  • Audit and Up List to OTCQB. Halitron has re-engaged Freidman LLP to complete the 2017 audit, which is one of the qualifying factors to up list to the OTCQB exchange. Friedman was previously engaged to provide audit work for the period ending September 30, 2016 and will continue to finalize the project through September 30, 2017 over the coming months. Management will be adding another accounting intern to help support the growing business as well as focus on completing the audit for the period ending September 30, 2017.
  • Share Buy Back. Another requirement for the up list is a share price of $0.01 or higher and the Company, as previously announced, is currently engaged in a share buyback program to help support increased share price. Management is forecasting increased purchases quarter-over-quarter based on projected increasing cash flows, as the New York facility is closed, and the Company reaps the benefits of reduced overhead. Forecasted increasing sales from the new product launch and cross-selling initiatives will also have a positive impact on this project.
  • Sales have increased to approximately $407K in Q4, 2017, which represents 150% over approximately $163K for Q3 3017. There were no sales for 2016 to compare, as the strategic acquisition is now the foundation for the team to build on.

According to OTC Markets, the current market cap of Halitron, Inc. (OTC Pink: HAON) is approximately $2.1 million and as such, its shares can have a dramatic upside.

HAON may not be at these levels much longer.

See the Press Release and more on Halitron, Inc. (OTC Pink: HAON) at EmergingGrowth.com
http://emerginggrowth.com/?s=haon

Other Companies in the news and featured on EmergingGrowth.com

Life Clips, Inc.
After what seems like countless months of low to mediocre trading, OTC stop sign company Life Clips, Inc. (OTC: LCLP) gained a bit of life.  The company traded over $1 million in dollar volume over the past two sessions.  The only new information in the market that we have seen is a request to withdraw a registration statement on form S-1.  Candlesticks are indicating a down turn so that could be the end of the run.

Have a look at Halitron, Inc.’s (OTC Pink: HAON) who just announced that it expects $4 million in sales from its recent merger.

RushNet, Inc.
RushNet, Inc. (OTC Pink: RSHN) began its 500% run on July 13th, a week prior to any news announcements.  Since July 20th, we’ve seen about 5 press releases discussing trademarks.  Its’ recent Q for period ending June 30, 2018, show zero sales, and 18 billion fully diluted shares outstanding.  With a $44 million market cap, I’m afraid that this run could do an about face any day now. 

Andiamo Corp.
Back in January, EmergingGrowth.com released the story “Andiamo (OTC Pink: ANDI) and the $100 million Pipe Dream”. https://emerginggrowth.com/andiamo-otc-pink-andi-100-million-pipe-dream/ The stock since has decreased 95% since the release of the article.  I’m willing to bet that, the little green candle stick from Friday represents a dead cat bounce.

Have a look at Halitron, Inc. (OTC Pink: HAON).  Sales are increasing quarterly, and a recent merger is expected to add about $4 million in additional revenue over the next 12 months.

About EmergingGrowth.com
EmergingGrowth.com is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies.  Through its evolution, EmergingGrowth.com found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization.  We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth.  Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community.  Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space. 

All information contained herein as well as on the EmergingGrowth.com website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of EmergingGrowth.com and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks.  This report is not without bias. EmergingGrowth.com has motivation by means of either self-marketing or EmergingGrowth.com has been compensated by or for a company or companies discussed in this article. Full details about which can be found in our full disclosure, which can be found here, http://www.emerginggrowth.com/disclosure-4266/. Please consult an investment professional before investing in anything viewed within. When EmergingGrowth.com is long shares it will sell those shares. In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the EmergingGrowth.com website.

CONTACT:
Company: EmergingGrowth.com – http://www.EmergingGrowth.com
Contact Email: info@EmergingGrowth.com
SOURCE: EmergingGrowth.com
 

https://ih.advfn.com/p.php?pid=nmona&article=78059030

DNA Dynamics, Inc. Issues Clarification on the Capital Structure of the Company

DNA Dynamics, Inc. Issues Clarification on the Capital Structure of the Company

New York, NY. — August 9, 2018 — InvestorsHub NewsWire — DNA Dynamics, Inc. (USOTC:DNAD) issues this  clarification on the capital stock formation of the company and confirms the following has been verified by the Transfer Agent as of 3:00pm EST on 08.09.2018:

Authorized Share Capital       5,000,000,000
Issued & Outstanding             4,306,946,928
Restricted Stock                      4,033,600,885
Unrestricted Stock                  273,346,043

The Company confirms that Mr. Lovatt has returned to treasury his book-entry 39,678,096, undeposited, free trading stock and that return is reflected in the above figures.

DNA will diligently update OTC Markets with these verified numbers today. OTC Markets will review the figures and update their website within a week in line with their terms & conditions.

There are also two additional physical certificates totalling 24,363,095 which are in the process of being returned to treasury but are still in issuance. These are also not deposited and are currently considered by the company to be ‘unrestricted stock’. A further update will be provided when the Transfer Agent has confirmed receipt and cancellation of the certificates. 

About DNA Dynamics, Inc.
Headquartered in Grandville, Michigan, and with operations in the UK, DNA Dynamics’ business focuses building a sustainable and stable Gaming and Crypto-currency ecosystem.
 For more information please email invest@dnadynamicsinc.com

Forward-Looking Statements
This press release may contain forward-looking statements, including information about management’s view of DNA Dynamics, Inc.’s future expectations, plans and prospects. In particular, when used in the preceding discussion, the words “believes,” “expects,” “intends,” “plans,” “anticipates,” or “may,” and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of DNA Dynamics, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on DNA Dynamics’ future results. The forward-looking statements included in this press release are made only as of the date hereof. DNA Dynamics cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, DNA Dynamics undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by DNA Dynamics.

 

https://ih.advfn.com/p.php?pid=nmona&article=78046848

The Possibility of Crypto Price Prediction

 

Bitcoin Global News (BGN)

August 09, 2018 — ADVFN Crypto NewsWire — On Monday, a Yale economist and a PHD candidate in his department publicly announced that they had found a way to predict price trends in what they call the “major cryptocurrencies,” which appeared to actually refer to Bitcoin alone.

Despite this, in the announcement, it was clarified that the study was actually published based on a seven year analysis of Bitcoin, Ripple, and Ethereum.

The researchers, Aleh Tsyvinski and Yukun Liu, have claimed that their findings are significant, which appears to be true, given the facts.

Cointelegraph reported that the team’s major finding was that these three Cryptocurrencies appear to have no real connection to the movement of the traditional stock market.

Furthermore, the study also found that the movement of these three Cryptocurrencies does not correlate with the movement of traditional currencies, commodities or other macroeconomic factors.

With all of this, their overarching conclusion was that related to price movements, Cryptocurrencies are only correlated to factors specific to their market.

You might be wondering at this point: what do we mean by these market specific factors?

One example is what Tsyvinski and Liu termed, “a strong time-series momentum effect,” which appears to mean something like if Bitcoin’s price consistently increases in the course of a week, then it should do the same in the next week.

Related to this, the team found that a significant, quick jump in Bitcoin’s price means a significant jump in demand, which in turn means, more investments in the market.

In connection with this, they said that the same seems to happen with Ethereum and Ripple, but at a smaller scale. Since this further connection has been proven in a quantitative study, it just might silence a few critics of these other networks, especially those who seem to consistently stand against Ripple’s progress.

The same report by Cointelegraph on the study mentioned one more market specific factors, which they call “investor attention.” This boils down to the idea that the price movement of these Cryptocurrencies is correlated with how many posts appear on social media and how many searches are done on Google, on Crypto related topics.

Given that this study apparently used 354 industries in the USA, as well as 137 in China to run its numbers, it can be taken as reliably executed and therefore, presenting valid findings.

As time goes on, it will be most interesting to see how other researchers try to add to this, especially with the difficulty of almost no correlation existing between Crypto and traditional markets.

Because this is true, discovering more quantitatively based market specific factors will be an undertaking since researchers will have to do so without historical information to compare the Crypto market to.

By: BGN Editorial Staff

News:

Cryptocurrency

https://ih.advfn.com/p.php?pid=nmona&article=78044842

DNA Dynamics, Inc. Welcomes Greg Trautman & Confirms Float Reduction Underway




DNA Dynamics, Inc. Welcomes Greg Trautman & Confirms Float Reduction Underway

 


New York, NY. — August 9, 2018 — InvestorsHub NewsWire — DNA Dynamics, Inc. (USOTC:DNAD) announces today that its subsidiary, DNA Interactive Limited has formed an advisory Board and welcomes its first member, Greg Trautman. The company is building a strong team around their Match Skillz platform and believes the appointment of Mr. Trautman and other, yet to be announced affiliations, will put them in a uniquely strong position at launch.


 DNA Dynamics CEO, Carl Grant commented that “I believe Greg will be a fantastic addition to our team and has already started the process of guiding us in terms of our route to market and our marketing strategy at launch. His experience is second to none and gives us a huge advantage in our space.”


 Talking from his offices in New York City, Mr Trautman stated that “With 35 years of direct handson experience working with early stage private and public companies, including several that went on to become major public companies, I’m thrilled to be joining the DNA team at this precise juncture. With my relevant gaming sector experience, which specifically included consulting work with multiple clients in online casino gaming and entertainment, I’m very enthusiastic about the global market penetration potential that MATCH SKILLZ possesses, as DNA prepares to launch this exciting new product.”


The Company also is pleased to inform shareholders that it is currently in the process of retiring three certificates totalling 64,041,191 free trading shares which have never been deposited


Paperwork has been submitted by all parties and the company is already working with the shareholder, Mr. Lovatt, on this reduction. We anticipate this will be completed by August 17th and the OTC Markets float will be updated at that time. This will result in the public float being 189,652,021 as of the end of August.




About DNA Dynamics, Inc.


Headquartered in Grandville, Michigan, and with operations in the UK, DNA Dynamics’ business focuses building a sustainable and stable Gaming and Crypto-currency ecosystem.


 For more information please email invest@dnadynamicsinc.com




About Greg Trautman


Mr Trautman has, over the past 22 years, served in the roles of C-Level executive, investment advisor, board member, and executive consultant for several public and private companies in multiple industries including financial services, technology, bio-tech, and online sales/marketing. Mr Trautman was involved in deals that raised over $1 billion dollars of financial capital for corporate expansion and venture capital for early-stage, high-potential, high risk, growth start-up technology and bio-tech companies. He was Instrumental in founding, funding and selling Connotate Technologies for $280M as well as a key player in obtaining the initial $15M of seed money for Shopping.com, helping build their comparative shopping technology platform, and the eventual sale of the company for $291M. Mr Trautman has also been named as one of the nation’s Top 50 venture capitalists by Microsoft for 3 consecutive years.


Forward-Looking Statements


This press release may contain forward-looking statements, including information about management’s view of DNA Dynamics, Inc.’s future expectations, plans and prospects. In particular, when used in the preceding discussion, the words “believes,” “expects,” “intends,” “plans,” “anticipates,” or “may,” and similar conditional expressions are intended to identify forward-looking statements. Any statements made in this news release other than those of historical fact, about an action, event or development, are forward-looking statements. These statements involve known and unknown risks, uncertainties and other factors, which may cause the results of DNA Dynamics, its subsidiaries and concepts to be materially different than those expressed or implied in such statements. Unknown or unpredictable factors also could have material adverse effects on DNA Dynamics’ future results. The forward-looking statements included in this press release are made only as of the date hereof. DNA Dynamics cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, DNA Dynamics undertakes no obligation to update these statements after the date of this release, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by DNA Dynamics.


 

https://ih.advfn.com/p.php?pid=nmona&article=78043951

Aben’s First Drill Hole Discovers Multiple High-Grade Zones Including 62.4 g/t Gold over 6.0m within 38.7 g/t Gold over 10.0m…

Suite 1610 – 777 Dunsmuir Street, Vancouver, BC, V7Y 1K4, CANADA
www.abenresources.com
.


TSX-V Trading Symbol:  ABN
        Email: info@abenresources.com
                                 Telephone: (604) 687-3376
                                  Facsimile:  (604) 687-3119

Aben’s First Drill Hole Discovers Multiple High-Grade Zones Including 62.4 g/t Gold over 6.0m within 38.7 g/t Gold over 10.0m at Forrest Kerr Project in BC’s Golden Triangle


Vancouver, BC — August 9, 2018 — InvestorsHub NewsWire — Aben Resources Ltd. (TSX-V: ABN) (OTCQB: ABNAF) (Frankfurt: E2L2) (the “Company”) is pleased to report that assay results from the first drill hole of 2018 have been received with multiple high-grade zones and precious metal values intersected in the hole at shallow depths. Drill hole FK18-10 was collared in the North Boundary Zone of the Forrest Kerr Property in BC’s Golden Triangle region where drilling late in the season in 2017 discovered strong precious and base metal mineralization. Hole FK18-10, the first of eight holes that have been drilled thus far, has four separate high-grade zones with the best zone returning and interval of 38.7 g/t Au over 10.0m including 62.4 g/t Au over 6.0m starting at 114 metres downhole.


Golden Triangle, B.C., claims map:


https://www.abenresources.com/site/assets/files/4728/abn_golden_triangle_map_1.1024×0.jpg

Highlights:


  • Four separate high-grade zones intersected in first drill hole FK18-10 all within 190 metres downhole at recently discovered North Boundary Zone
  • Highest-grade zone consists of 331.0 g/t (grams/tonne) gold (Au) (9.65 oz/t) over 1.0 metre (m) within broad zone averaging 38.7 g/t Au (1.12 oz/t) over 10.0m from 114.0-124.0m including 62.4 g/t Au over 6.0m (true thicknesses undetermined)
  • Additional high-grade zones in Hole FK18-10 include 22.0 g/t Au, 22.4 g/t silver (Ag) over 4.0m; 3.9 g/t Au, 4.0 g/t Ag over 13.0m; and  8.2 g/t Au, 1.4 g/t Ag over 6.0m (see table below for intervals in more detail)
  • This new discovery is part of the Boundary North Zone and is 230m north of the historic high-grade drill hole drilled by Noranda in 1991
  • Plans to expand the drill program are being put in place and assays are pending for seven more drill holes

Jim Pettit, President and CEO of Aben Resources stated, “The high-grade gold and base metal values in the first hole of the 2018 drill program have far exceeded our expectations and confirm the presence of a robust and strong mineralizing system at the recently discovered North Boundary Zone. We are now looking at an area that extends 230m south to the historic high-grade Noranda drill hole from 1991 and although the geology is complex we believe more drilling will delineate additional high-grade mineralization. The target areas in and around the Boundary Zone are relatively shallow and continue to provide strong discovery potential as we look to value-add the project using a systematic exploration methodology. With drilling ongoing, the Company is awaiting assay results from an additional seven drill holes, all of which were drilled at the North Boundary Zone and will provide updates as results become available. I would like to congratulate our geological team on their work thus far as we have made a significant discovery in the Golden Triangle region that is still in its early days with drilling slated to ramp up over the coming months.”

Ron Netolitzky, Chairman of Aben Resources, stated: “The presence of multiple mineralized zones associated with mesothermal veining and adjacent to major structural breaks is very encouraging. Close proximity to infrastructure will facilitate ongoing exploration.”

Overview of Drill Hole FK18-10 and Geological Description:

Hole FK18-10 (140/-45) was drilled from a location 35 metres northwest and along section from the drill pad from which the discovery holes FK17-04, 05 and 06 were drilled late in the drill season last year in August/September. The new hole has further defined and significantly increased the zone of precious and base metal mineralization that the 2017 holes originally intersected. Of particular note, the high-grade interval of 331.0 g/t Au was encountered 230 metres north of a 326 g/t Au interval reported by Noranda in 1991 in drill hole RG91-16 (see attached plan map). High-grade intercepts are generally found in narrow and discrete zones of moderate mineralization within a broad envelope of lower grade mineralization. Mineralization at North Boundary reflects the poly-metallic nature of the core with widely variable values of Au, Ag, Cu, Pb and Zn throughout.

Boundary North Plan View map:
https://abenresources.com/site/assets/files/4826/abn-boundary-north-plan-map-2018.jpg

With drilling currently ongoing, final geochemical assays results for seven completed holes are still pending and the Company will look to expand the scope of the program given the results from the first hole and visual indicators in the other holes. This recently discovered North Boundary Zone shows very little outcrop exposure and contains complex geology which is disrupted by a series of faults of unknown orientation. Additional drilling is required to determine true thicknesses and establish controls to the mineralization
  
Previously reported and select results from the few 2017 drill holes at North Boundary include 6.7 g/t Au, 6.4 g/t Ag and 0.9% Cu over 10.0m including 18.9 g/t Au, 16.6 g/t Ag and 2.2% Cu over 3.0m in hole FK17-04 which contributed to an average grade of 0.26 g/t Au over 387.0m. Hole FK17-05 returned 21.5 g/t Au, 28.5 g/t Ag and 3.1% Cu over 6.0m from the same zone at a slightly greater depth.

Boundary North Cross Section map:
https://abenresources.com/site/assets/files/4826/abn-boundary-north-cross-section-aug-2018.jpg

Mineralization at North Boundary is structurally controlled and hosted in a package of volcanic and volcaniclastic rocks from the Jurassic Hazelton Group. Several generations of quartz and quartz-carbonate veining are important hosts to mineralization, as are subordinate breccia zones with strong chlorite, hematite and carbonate alteration. The Boundary Zone lies between the Forrest Kerr Fault to the west, a major deep-seated crustal feature, and the unconformable contact between the Jurassic Hazelton Group and the Triassic Stuhini Group to the East. The rock reflects a prolonged history of strong hydrothermal activity combined with brittle deformation. The host package Hazelton is known to be a prolific host to several deposits throughout the region.  


Analytical and QA/QC Description:



All 1 or 2 metre drill core samples were delivered to ALS Global prep facility in Terrace, British Columbia where they were crushed until 70% passed a 2mm sieve, then a 250g split was pulverized until better than 85% passed a 75 micron screen. Gold was tested via fire assay method Au-ICP21 with all ore-grade samples (>10 g/t) undergoing fire assay with gravimetric finish. ALS performed multi-element ICP-AES package ME-ICP41 in their Vancouver facility to test for 35 other elements. In addition to the quality assurance and quality control program performed by ALS, Aben personnel insert lab certified standards, field blanks and duplicates into the sample stream at the rate of one QA/QC sample in every 10 samples.

Cornell McDowell, P.Geo., V.P. of Exploration of Aben Resources, has reviewed and approved the technical aspects of this news release and is the Qualified Person as defined by National Instrument 43-101.

About Aben Resources:

Aben Resources is a Canadian gold exploration company advancing projects in British Columbia’s Golden Triangle, the Yukon and Saskatchewan. The Company is actively exploring its flagship and high-grade Forrest Kerr Project located in the Golden Triangle region where recent drilling has discovered strong precious and base metal mineralization at the North Boundary Zone.

For further information on Aben Resources Ltd. (TSX-V: ABN), visit our Company’s web site at www.abenresources.com.

Aben Resources has approx. 81.5 million shares issued and outstanding.

ABEN RESOURCES LTD.

“Jim Pettit”
 ____________________________
JAMES G. PETTIT
President & CEO

For further information contact myself or:
Don Myers
Aben Resources Ltd.
Director, Corporate Communications
Telephone: 604-687-3376
Toll Free: 800-567-8181
Facsimile: 604-687-3119
Email: info@abenresources.com

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This release includes certain statements that may be deemed to be “forward-looking statements”. All statements in this release, other than statements of historical facts, that address events or developments that management of the Company expects, are forward-looking statements. Although management believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance, and actual results or developments may differ materially from those in the forward-looking statements. The Company undertakes no obligation to update these forward-looking statements if management’s beliefs, estimates or opinions, or other factors, should change. Factors that could cause actual results to differ materially from those in forward-looking statements, include market prices, exploration and development successes, continued availability of capital and financing, and general economic, market or business conditions. Please see the public filings of the Company at www.sedar.com for further information.

 

https://ih.advfn.com/p.php?pid=nmona&article=78042595

Walmart.com Successfully Launched InnerScope Hearing Technologies’ Direct-To-Consumer Hearing Aid Devices & Personal Sound

 

Walmart.com Successfully Launched InnerScope Hearing TechnologiesDirect-To-Consumer Hearing Aid Devices & Personal Sound Amplifiers Products Sold Online As The Retailer

The Company, as a supplier and a direct ship vendor (DSV) for Walmart.com, is ramping-up its inventory of FDA-Registered hearing aid devices and personal sound amplifiers products for Walmart.com‘s customers.

 

Roseville, CA — August 09, 2018 — InvestorsHub NewsWire — InnerScope Hearing Technologies Inc. (OTCQB: INND) announce today that Walmart.com has successfully launched the Company’s FDA-Registered Hearing Aids and its Personal Sound Amplifier Products (“PSAPs”) to be sold Direct-To-Consumer to Walmart.com‘s online customers. The Company, as a contract supplier and a direct ship vendor aka drop ship vendor (“DSV”) for Walmart.com, has been preparing for the launch by ramping-up multiple skews of its PSAPs and hearing aid device inventory, ready to be shipped directly to Walmart.com customers upon order. The Company prides itself on continuing to deliver on its mission by providing Direct-To-Consumer easy access of the latest in high quality hearing aid technology at very affordable prices.

Walmart.com along with InnerScope is continuing to enhance the format, language and listing for all of the Company’s products on the web pages on Walmart.com These enhancements will allow Walmart.com‘s customers to have increased visibility and understanding of the differences between each hearing product listing for ease of ordering. InnerScope as a DSV supplier to Walmart.com will be continuing to add more high quality hearing aid and hearing assistive products to Walmart.com‘s listing and web pages.

InnerScopes’s ALPHA 3-5-9 Series are FDA-Registered receiver-in-canals (RICs) Digital Hearing Aids. The ALPHA‘s are a very small discreet compact design and comfortable with Bluetooth Low Energy (BLE) wireless technology (for direct connection to external Bluetooth-enable devices) with a user app for added user control and personalizing the hearing aids for all different environments via Android or iOS Smartphone’s. The ALPHA Series with Bluetooth and a Smart Control App is offered in 3 levels of technology based on affordability and hearing needs.

The ALPHA 3 hearing aid has a digital processor that consists of 4-channels and 8-frequency bands with 4 separated user programs. The ALPHA 3 is suitable for mild to moderately severe hearing losses and includes a Basic Instantaneous Noise and Surround Sound Processor. The APLHA 3 offers Best-Value and affordability with its basic features designed for moderately active lifestyles. Click Here for the link to the Walmart.com‘s Alpha 3 page.

The ALPHA 5 hearing aid has a digital processor that consists of 12-channels and 16-frequency bands with 5 separated user programs. The ALPHA 5 is suitable for mild to moderately severe hearing losses and includes an Automatic Intelligent Switching for Different Environments, Advanced Instantaneous Noise and Surround Sound Processor. The APLHA 5 and its Advanced features are designed for more active lifestyles that requires hearing in many different environments. Click Here for the link to the Walmart.com‘s Alpha 5 page.

The ALPHA 9 hearing aid has a digital processor that consists of 16-channels and 16-frequency bands with 6 separated user programs. The ALPHA 9 is suitable for mild to moderately severe hearing losses and includes Best-in-Class Automatic Intelligent Switching for Different Environments with Instantaneous Noise and Surround Sound Processor. The APLHA 9 and its Best-in-Class features are designed for the most active lifestyles that requires the best opportunity to hear clearly in the most demanding environments. Click Here for the link to the Walmart.com‘s Alpha 9 page.

The Teeny PSAP is a patented audiologist designed earlevel PSAP which uses the same Advanced Digital Technology found in higher priced hearing aid devices. The Teeny is a one size fits all completely-in-the-canal (CIC), made to be comfortably hidden within the ear canal. Click Here for the link to the Walmart.com‘s Teeny PSAP page.

The Crescent PSAPa patented audiologist designed earlevel PSAP which also like the Teeny PSAP, uses the same Advanced Digital Technology found in higher priced hearing aid devices. The Crescent with its unique universal shell design fits approximately 95% of all ears. Click Here for the link to the Walmart.com‘s Crescent PSAP page.

The BlackCat PSAP is a hearable/wearable personal audio controller designed for people who have difficulty understanding conversation in difficult listening and noisy situations, like in a restaurant or group gatherings. Its compact credit card design and easy to use buttons for the user to control volume, balance and rear noise suppression. Click Here for the link to the Walmart.com‘s BlackCat PSAP page.

“We could not have been more pleased with working with Walmart.com for helping them to promote our affordable high quality hearing aids and hearing assistive products, said Matthew Moore, CEO of InnerScope Hearing Technologies. “We are proud to have Walmart.com choose our hearing aids and hearing assistive products for their customers. With the current average cost of hearing aids running about $5000.00, a set, it’s no wonder why, there is only 7 to 8 million Americans that currently use hearing aids when there are over 48 million that have reported some hearing loss and could benefit from using hearing aids or some hearing assistance. InnerScope’s agreement with Walmart.com, gives the Company and Walmart.com the opportunity to sell the 48 million Americans an affordable alternative to the traditional high cost of hearing aids at 75% to 80% less than the current average cost. Not to mention, the revenue potential is off the charts for both the Company and Walmart.com. Each person has two ears, that’s 96 million potential hearing aid sales.” continued Mr. Moore.

“We know the cost of hearing aids is just too high for most people that need them. However, there is even a greater cost that very few ever know about. The “real” cost is much higher than the actual dollars spent. For those approximately 42 million Americans that suffer from hearing loss and could not afford to purchased hearing aids, are potentially at high risk and in-fact, could be jeopardizing their overall health and well-being. Proper auditory stimulation from the use of hearing aids may reduce health issues associated with of untreated hearing loss, including cognitive issues, such as Dementia and Alzheimer’s disease. We believe with Walmart.com as retailer of InnerScope’s hearing products, more people will recognize the need to treat their hearing issues sooner than later and thereby reducing unnecessary health risks, due to untreated hearing loss.” Mr. Moore concluded

 

About InnerScope Hearing Technologies (INND):

InnerScope Hearing Technologies (INND) is a technology driven company with highly scalable B2B and B2C solutions. The Company plans on offering a B2B SaaS based Patient Management System (PMS) software program, designed to improve operations and communication with patients. INND also offers a Buying Group experience for audiology practice, enabling owners to lower product costs and increase their margins. INND will also compete in the DTC (Direct-to-Consumer) markets with its own line of “Hearable”, and “Wearable” Personal Sound Amplifier Products (PSAPs) and revolutionary APPs on the iOS and Android markets.

INND has plans on opening, operating and expanding a chain of audiological and retail hearing device clinics. INND’s seasoned team of professionals, with collectively over 200+ years of experience in the hearing aid industry, including successful operations in hearing aid manufacturing and retail store management. Our team has the knowledge, relationships, and the experience to quickly deploy new products and software to serve approximately 1.2 billion people around the globe that are suffering with 25 db or greater hearing loss. For more information, please visit: www.innd.com

About Walmart.com

Wal-Mart.com USA, LLC, a wholly-owned subsidiary of Wal-Mart Stores, Inc. was founded in 2000 and is headquartered in Brisbane, California. The company offers online retail services and sells products in various categories within in the United States, APO/FPO military addresses, Samoa, Guam, Northern Mariana Islands, Puerto Rico, and Virgin Islands.

 

Safe Harbor

This presentation contains forward-looking statements which relate to future events or InnerScope Hearing Technologies future performance or financial condition. Any statements that are not statements of historical fact (including statements containing the words “believes,” “should,” “plans,” “anticipates,” “expects,” “estimates” and similar expressions) should also be considered to be forward-looking statements. These forward-looking statements are not guarantees of future performance, condition or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as result of a number of factors, including those described from time to time in InnerScope Hearing Technologies filings with the Securities and Exchange Commission. InnerScope Hearing Technologies undertakes no duty to update any forward-looking statements made herein.

 

 

Contact:

InnerScope Hearing Technologies, Inc. 
Matthew Moore

Matthew@innd.com
916-218-4100
www.innd.com

 

 

www.walmart.com

www.innd.com

https://www.nohasslehearing.com

https://www.hearingbenefit.com

 

Links to InnerScope Hearing Technologies’ Hearing Aids on Walmart.com:

Alpha 3 Hearing Aid by InnerScope Hearing Technologies:

https://www.walmart.com/ip/Alpha-3-Hearing-Aid-Smartphone-Enabled-Premium-Hearing-Device-Patented-Noise-Blocking-System-Right-or-Left/723285115

 

Alpha 5 Hearing Aid by InnerScope Hearing Technologies:

https://www.walmart.com/ip/Alpha-5-Hearing-Aid-Smartphone-Enabled-Premium-Hearing-Device-Patented-Noise-Blocking-System-Right-or-Left/708900558

 

Alpha 9 Hearing Aid by InnerScope Hearing Technologies:

https://www.walmart.com/ip/Alpha-9-Hearing-Aid/679890260

 

Links to InnerScope Hearing Technologies’ Personal Sound Amplifiers (PSAPs) on Walmart.com:

 

Teeny Personal Sound Amplifier:

https://www.walmart.com/ip/Teeny-Sound-Amplifier-Fits-Either-Ear-Clear-Color-Premium-In-the-Ear-Sound-Amplification/272111527

 

Crescent Personal Sound Amplifier:

https://www.walmart.com/ip/Crescent-Sound-Amplifier/915134470

 

BlackCat Personal Sound Amplifier:

https://www.walmart.com/ip/BlackCat-Personalized-Sound-Amplifier/542735795

 

https://ih.advfn.com/p.php?pid=nmona&article=78042394